| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | calcium ion binding | DCHS2 CALM1 PAMR1 CALM2 CALM3 PPP2R3B RCN2 CALML5 LRP1B CRB1 TGM3 EYS CELSR1 HMCN1 PCDHGA12 MMP12 PCDH7 | 5.44e-07 | 749 | 108 | 17 | GO:0005509 |
| GeneOntologyMolecularFunction | titin binding | 7.77e-07 | 14 | 108 | 4 | GO:0031432 | |
| GeneOntologyMolecularFunction | adenylate cyclase activator activity | 1.53e-06 | 5 | 108 | 3 | GO:0010856 | |
| GeneOntologyMolecularFunction | type 3 metabotropic glutamate receptor binding | 3.04e-06 | 6 | 108 | 3 | GO:0031800 | |
| GeneOntologyMolecularFunction | ATP-dependent protein disaggregase activity | 3.04e-06 | 6 | 108 | 3 | GO:0140545 | |
| GeneOntologyMolecularFunction | C3HC4-type RING finger domain binding | 3.04e-06 | 6 | 108 | 3 | GO:0055131 | |
| GeneOntologyMolecularFunction | actin filament binding | 3.99e-06 | 227 | 108 | 9 | GO:0051015 | |
| GeneOntologyMolecularFunction | adenylate cyclase regulator activity | 1.26e-05 | 9 | 108 | 3 | GO:0010854 | |
| GeneOntologyMolecularFunction | nitric-oxide synthase regulator activity | 1.80e-05 | 10 | 108 | 3 | GO:0030235 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | KIF21B WAS KIF27 CALM1 NEBL IQGAP2 CALM2 CALM3 SYNE1 SPTBN1 SPTBN2 OBSCN DRG1 SPTBN4 SYNE3 AVIL CTNNA2 UTRN | 2.35e-05 | 1099 | 108 | 18 | GO:0008092 |
| GeneOntologyMolecularFunction | cyclase activator activity | 4.23e-05 | 13 | 108 | 3 | GO:0010853 | |
| GeneOntologyMolecularFunction | actin binding | WAS NEBL IQGAP2 SYNE1 SPTBN1 SPTBN2 SPTBN4 SYNE3 AVIL CTNNA2 UTRN | 5.74e-05 | 479 | 108 | 11 | GO:0003779 |
| GeneOntologyMolecularFunction | protein-containing complex destabilizing activity | 6.68e-05 | 15 | 108 | 3 | GO:0140776 | |
| GeneOntologyMolecularFunction | structural constituent of cytoskeleton | 7.54e-05 | 130 | 108 | 6 | GO:0005200 | |
| GeneOntologyMolecularFunction | G protein-coupled glutamate receptor binding | 8.19e-05 | 16 | 108 | 3 | GO:0035256 | |
| GeneOntologyMolecularFunction | adenylate cyclase binding | 8.19e-05 | 16 | 108 | 3 | GO:0008179 | |
| GeneOntologyMolecularFunction | denatured protein binding | 8.66e-05 | 3 | 108 | 2 | GO:0031249 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | SPTBN1 SPTBN2 OBSCN LAMA5 ADGRL1 YKT6 CTNNA2 BCAM HSPA1A GCN1 UTRN HSPA8 | 9.64e-05 | 599 | 108 | 12 | GO:0050839 |
| GeneOntologyMolecularFunction | protein phosphatase activator activity | 9.90e-05 | 17 | 108 | 3 | GO:0072542 | |
| GeneOntologyMolecularFunction | protein-membrane adaptor activity | 1.02e-04 | 45 | 108 | 4 | GO:0043495 | |
| GeneOntologyMolecularFunction | cyclase regulator activity | 1.18e-04 | 18 | 108 | 3 | GO:0010851 | |
| GeneOntologyMolecularFunction | phosphatase activator activity | 1.64e-04 | 20 | 108 | 3 | GO:0019211 | |
| GeneOntologyMolecularFunction | nitric-oxide synthase binding | 2.20e-04 | 22 | 108 | 3 | GO:0050998 | |
| GeneOntologyMolecularFunction | ankyrin binding | 2.52e-04 | 23 | 108 | 3 | GO:0030506 | |
| GeneOntologyMolecularFunction | semaphorin receptor binding | 2.52e-04 | 23 | 108 | 3 | GO:0030215 | |
| GeneOntologyMolecularFunction | death receptor agonist activity | 2.87e-04 | 5 | 108 | 2 | GO:0038177 | |
| GeneOntologyMolecularFunction | cytoskeleton-nuclear membrane anchor activity | 2.87e-04 | 5 | 108 | 2 | GO:0140444 | |
| GeneOntologyMolecularFunction | chemorepellent activity | 5.08e-04 | 29 | 108 | 3 | GO:0045499 | |
| GeneOntologyMolecularFunction | cadherin binding | 5.13e-04 | 339 | 108 | 8 | GO:0045296 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activator activity | 8.49e-04 | 78 | 108 | 4 | GO:0043539 | |
| GeneOntologyMolecularFunction | glutamate receptor binding | 9.78e-04 | 81 | 108 | 4 | GO:0035254 | |
| GeneOntologyMolecularFunction | ATP-dependent protein folding chaperone | 1.31e-03 | 40 | 108 | 3 | GO:0140662 | |
| GeneOntologyMolecularFunction | structural constituent of muscle | 1.62e-03 | 43 | 108 | 3 | GO:0008307 | |
| GeneOntologyMolecularFunction | phosphatidylinositol 3-kinase binding | 1.62e-03 | 43 | 108 | 3 | GO:0043548 | |
| GeneOntologyMolecularFunction | calcium-dependent protein binding | 1.98e-03 | 98 | 108 | 4 | GO:0048306 | |
| GeneOntologyMolecularFunction | protein phosphatase regulator activity | 2.13e-03 | 100 | 108 | 4 | GO:0019888 | |
| GeneOntologyMolecularFunction | calcium channel inhibitor activity | 2.17e-03 | 13 | 108 | 2 | GO:0019855 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 2.73e-03 | 441 | 108 | 8 | GO:0016887 | |
| GeneOntologyMolecularFunction | phospholipid binding | 2.92e-03 | 548 | 108 | 9 | GO:0005543 | |
| GeneOntologyMolecularFunction | structural molecule activity | NEBL KRT84 SPTBN1 SPTBN2 OBSCN LAMA5 SPTBN4 TGM3 KRT76 HMCN1 MYOM2 CTNNA2 | 3.16e-03 | 891 | 108 | 12 | GO:0005198 |
| GeneOntologyMolecularFunction | efflux transmembrane transporter activity | 3.31e-03 | 16 | 108 | 2 | GO:0015562 | |
| GeneOntologyMolecularFunction | Arp2/3 complex binding | 3.31e-03 | 16 | 108 | 2 | GO:0071933 | |
| GeneOntologyMolecularFunction | phosphatase regulator activity | 3.32e-03 | 113 | 108 | 4 | GO:0019208 | |
| GeneOntologyMolecularFunction | misfolded protein binding | 4.19e-03 | 18 | 108 | 2 | GO:0051787 | |
| GeneOntologyMolecularFunction | phosphatidylinositol phosphate binding | 4.55e-03 | 199 | 108 | 5 | GO:1901981 | |
| GeneOntologyMolecularFunction | death receptor activity | 5.69e-03 | 21 | 108 | 2 | GO:0005035 | |
| GeneOntologyBiologicalProcess | positive regulation of cyclic-nucleotide phosphodiesterase activity | 1.28e-07 | 3 | 105 | 3 | GO:0051343 | |
| GeneOntologyBiologicalProcess | negative regulation of calcium ion export across plasma membrane | 1.27e-06 | 5 | 105 | 3 | GO:1905913 | |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | WAS NEBL IQGAP2 ADAMTS2 KRT84 SPTBN1 SPTBN2 OBSCN OBSL1 DRG1 SPTBN4 KRT76 AVIL MYOM2 CTNNA2 HSPA1A HSPA1B HSPA8 | 1.49e-06 | 957 | 105 | 18 | GO:0097435 |
| GeneOntologyBiologicalProcess | regulation of calcium ion export across plasma membrane | 2.54e-06 | 6 | 105 | 3 | GO:1905912 | |
| GeneOntologyBiologicalProcess | regulation of cyclic-nucleotide phosphodiesterase activity | 2.54e-06 | 6 | 105 | 3 | GO:0051342 | |
| GeneOntologyBiologicalProcess | autophagosome membrane docking | 7.05e-06 | 8 | 105 | 3 | GO:0016240 | |
| GeneOntologyBiologicalProcess | negative regulation of high voltage-gated calcium channel activity | 7.05e-06 | 8 | 105 | 3 | GO:1901842 | |
| GeneOntologyBiologicalProcess | synapse organization | SEMA3F SPTBN2 LAMA5 ADGRL1 NBEA PLXND1 CSMD2 SPTBN4 CAMKV SNX27 TANC1 CTNNA2 HSPA8 SEMA3E | 9.80e-06 | 685 | 105 | 14 | GO:0050808 |
| GeneOntologyBiologicalProcess | positive regulation of ryanodine-sensitive calcium-release channel activity | 1.05e-05 | 9 | 105 | 3 | GO:0060316 | |
| GeneOntologyBiologicalProcess | protein-containing complex disassembly | 1.80e-05 | 291 | 105 | 9 | GO:0032984 | |
| GeneOntologyBiologicalProcess | negative regulation of ryanodine-sensitive calcium-release channel activity | 2.05e-05 | 11 | 105 | 3 | GO:0060315 | |
| GeneOntologyBiologicalProcess | calcium ion export across plasma membrane | 2.73e-05 | 12 | 105 | 3 | GO:1990034 | |
| GeneOntologyBiologicalProcess | regulation of cell communication by electrical coupling involved in cardiac conduction | 2.73e-05 | 12 | 105 | 3 | GO:1901844 | |
| GeneOntologyBiologicalProcess | mitotic cell cycle process | CALM1 IQGAP2 CALM2 CALM3 SPTBN1 PPP2R3B OBSL1 CUL7 SIRT1 DRG1 MEPCE EXOC1 HSPA1A HSPA1B HSPA8 | 2.74e-05 | 854 | 105 | 15 | GO:1903047 |
| GeneOntologyBiologicalProcess | detection of calcium ion | 3.53e-05 | 13 | 105 | 3 | GO:0005513 | |
| GeneOntologyBiologicalProcess | actin cytoskeleton organization | WAS NEBL IQGAP2 SPTBN1 SPTBN2 OBSCN OBSL1 SPTBN4 CELSR1 HMCN1 AVIL MYOM2 CTNNA2 FGD6 | 5.64e-05 | 803 | 105 | 14 | GO:0030036 |
| GeneOntologyBiologicalProcess | negative regulation of supramolecular fiber organization | 6.73e-05 | 197 | 105 | 7 | GO:1902904 | |
| GeneOntologyBiologicalProcess | regulation of high voltage-gated calcium channel activity | 6.84e-05 | 16 | 105 | 3 | GO:1901841 | |
| GeneOntologyBiologicalProcess | cellular component disassembly | CALM1 CALM2 SPTBN1 SPTBN2 ATG14 SPTBN4 AVIL SUPT16H FGFR4 MMP12 GCN1 HSPA8 | 7.14e-05 | 617 | 105 | 12 | GO:0022411 |
| GeneOntologyBiologicalProcess | organelle localization by membrane tethering | 7.37e-05 | 85 | 105 | 5 | GO:0140056 | |
| GeneOntologyBiologicalProcess | regulation of supramolecular fiber organization | WAS SPTBN1 SPTBN2 DRG1 SPTBN4 AVIL CTNNA2 HSPA1A HSPA1B HSPA8 | 8.04e-05 | 438 | 105 | 10 | GO:1902903 |
| GeneOntologyBiologicalProcess | negative regulation of release of sequestered calcium ion into cytosol | 8.28e-05 | 17 | 105 | 3 | GO:0051280 | |
| GeneOntologyBiologicalProcess | cytokinesis | 8.38e-05 | 204 | 105 | 7 | GO:0000910 | |
| GeneOntologyBiologicalProcess | actin filament capping | 8.78e-05 | 46 | 105 | 4 | GO:0051693 | |
| GeneOntologyBiologicalProcess | regulation of cell communication by electrical coupling | 9.89e-05 | 18 | 105 | 3 | GO:0010649 | |
| GeneOntologyBiologicalProcess | membrane docking | 1.02e-04 | 91 | 105 | 5 | GO:0022406 | |
| GeneOntologyBiologicalProcess | positive regulation of sequestering of calcium ion | 1.17e-04 | 19 | 105 | 3 | GO:0051284 | |
| GeneOntologyBiologicalProcess | cell junction organization | SEMA3F SPTBN2 LAMA5 MPDZ ADGRL1 NBEA PLXND1 CSMD2 SPTBN4 CAMKV SNX27 TANC1 CTNNA2 HSPA8 SEMA3E | 1.21e-04 | 974 | 105 | 15 | GO:0034330 |
| GeneOntologyBiologicalProcess | negative regulation of actin filament depolymerization | 1.42e-04 | 52 | 105 | 4 | GO:0030835 | |
| GeneOntologyBiologicalProcess | semaphorin-plexin signaling pathway | 1.42e-04 | 52 | 105 | 4 | GO:0071526 | |
| GeneOntologyBiologicalProcess | negative regulation of voltage-gated calcium channel activity | 1.59e-04 | 21 | 105 | 3 | GO:1901386 | |
| GeneOntologyBiologicalProcess | presynaptic endocytosis | 1.75e-04 | 102 | 105 | 5 | GO:0140238 | |
| GeneOntologyBiologicalProcess | regulation of cytoskeleton organization | WAS IQGAP2 SPTBN1 SPTBN2 DRG1 SPTBN4 CELSR1 AVIL CTNNA2 HSPA1A HSPA1B | 1.78e-04 | 579 | 105 | 11 | GO:0051493 |
| GeneOntologyBiologicalProcess | regulation of protein polymerization | 1.81e-04 | 231 | 105 | 7 | GO:0032271 | |
| GeneOntologyBiologicalProcess | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion | 1.84e-04 | 22 | 105 | 3 | GO:0010881 | |
| GeneOntologyBiologicalProcess | mitotic cell cycle | CALM1 IQGAP2 CALM2 CALM3 SPTBN1 PPP2R3B OBSL1 CUL7 SIRT1 DRG1 MEPCE EXOC1 HSPA1A HSPA1B HSPA8 | 1.88e-04 | 1014 | 105 | 15 | GO:0000278 |
| GeneOntologyBiologicalProcess | regulation of postsynaptic membrane neurotransmitter receptor levels | 1.94e-04 | 164 | 105 | 6 | GO:0099072 | |
| GeneOntologyBiologicalProcess | organelle assembly | KIF27 NEBL SYNE1 SPTBN2 OBSCN OBSL1 LAMA5 ABCB6 ATG14 CSMD2 DRG1 AP1B1 AVIL MYOM2 HSPA1A HSPA1B | 2.01e-04 | 1138 | 105 | 16 | GO:0070925 |
| GeneOntologyBiologicalProcess | actin filament-based process | WAS NEBL IQGAP2 SPTBN1 SPTBN2 OBSCN OBSL1 SPTBN4 CELSR1 HMCN1 AVIL MYOM2 CTNNA2 FGD6 | 2.15e-04 | 912 | 105 | 14 | GO:0030029 |
| GeneOntologyBiologicalProcess | regulation of mitotic spindle assembly | 2.40e-04 | 24 | 105 | 3 | GO:1901673 | |
| GeneOntologyBiologicalProcess | negative regulation of peptidyl-threonine phosphorylation | 2.40e-04 | 24 | 105 | 3 | GO:0010801 | |
| GeneOntologyBiologicalProcess | regulation of actin filament depolymerization | 2.65e-04 | 61 | 105 | 4 | GO:0030834 | |
| GeneOntologyBiologicalProcess | neural crest cell migration | 2.82e-04 | 62 | 105 | 4 | GO:0001755 | |
| GeneOntologyBiologicalProcess | regulation of ryanodine-sensitive calcium-release channel activity | 3.06e-04 | 26 | 105 | 3 | GO:0060314 | |
| GeneOntologyBiologicalProcess | cell communication by electrical coupling involved in cardiac conduction | 3.06e-04 | 26 | 105 | 3 | GO:0086064 | |
| GeneOntologyBiologicalProcess | protein polymerization | 3.10e-04 | 334 | 105 | 8 | GO:0051258 | |
| GeneOntologyBiologicalProcess | mesenchymal cell migration | 3.19e-04 | 64 | 105 | 4 | GO:0090497 | |
| GeneOntologyBiologicalProcess | actin filament depolymerization | 3.59e-04 | 66 | 105 | 4 | GO:0030042 | |
| GeneOntologyBiologicalProcess | trunk neural crest cell migration | 3.80e-04 | 6 | 105 | 2 | GO:0036484 | |
| GeneOntologyBiologicalProcess | cellular heat acclimation | 3.80e-04 | 6 | 105 | 2 | GO:0070370 | |
| GeneOntologyBiologicalProcess | trunk segmentation | 3.80e-04 | 6 | 105 | 2 | GO:0035290 | |
| GeneOntologyBiologicalProcess | regulation of cardiac muscle contraction by calcium ion signaling | 3.83e-04 | 28 | 105 | 3 | GO:0010882 | |
| GeneOntologyBiologicalProcess | vacuolar transport | 3.92e-04 | 187 | 105 | 6 | GO:0007034 | |
| GeneOntologyBiologicalProcess | positive regulation of protein autophosphorylation | 4.25e-04 | 29 | 105 | 3 | GO:0031954 | |
| GeneOntologyBiologicalProcess | protein refolding | 4.71e-04 | 30 | 105 | 3 | GO:0042026 | |
| GeneOntologyBiologicalProcess | regulation of cardiac muscle cell action potential | 4.71e-04 | 30 | 105 | 3 | GO:0098901 | |
| GeneOntologyBiologicalProcess | negative regulation of cytoskeleton organization | 4.77e-04 | 194 | 105 | 6 | GO:0051494 | |
| GeneOntologyBiologicalProcess | regulation of heart rate | 5.19e-04 | 129 | 105 | 5 | GO:0002027 | |
| GeneOntologyBiologicalProcess | positive regulation of phosphatase activity | 5.19e-04 | 31 | 105 | 3 | GO:0010922 | |
| GeneOntologyBiologicalProcess | heat acclimation | 5.30e-04 | 7 | 105 | 2 | GO:0010286 | |
| GeneOntologyBiologicalProcess | positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway | 5.30e-04 | 7 | 105 | 2 | GO:0070434 | |
| GeneOntologyBiologicalProcess | positive regulation of peptidyl-threonine phosphorylation | 5.71e-04 | 32 | 105 | 3 | GO:0010800 | |
| GeneOntologyBiologicalProcess | negative regulation of actin filament polymerization | 5.84e-04 | 75 | 105 | 4 | GO:0030837 | |
| GeneOntologyBiologicalProcess | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum | 6.26e-04 | 33 | 105 | 3 | GO:0010880 | |
| GeneOntologyBiologicalProcess | regulation of spindle assembly | 6.84e-04 | 34 | 105 | 3 | GO:0090169 | |
| GeneOntologyBiologicalProcess | positive regulation of microtubule nucleation | 7.05e-04 | 8 | 105 | 2 | GO:0090063 | |
| GeneOntologyBiologicalProcess | positive regulation of nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway | 7.05e-04 | 8 | 105 | 2 | GO:0070426 | |
| GeneOntologyBiologicalProcess | cell communication by electrical coupling | 7.45e-04 | 35 | 105 | 3 | GO:0010644 | |
| GeneOntologyBiologicalProcess | chaperone cofactor-dependent protein refolding | 7.45e-04 | 35 | 105 | 3 | GO:0051085 | |
| GeneOntologyBiologicalProcess | regulation of actin cytoskeleton organization | 7.78e-04 | 384 | 105 | 8 | GO:0032956 | |
| GeneOntologyBiologicalProcess | cellular response to heat | 7.81e-04 | 81 | 105 | 4 | GO:0034605 | |
| GeneOntologyBiologicalProcess | protein depolymerization | 8.53e-04 | 144 | 105 | 5 | GO:0051261 | |
| GeneOntologyBiologicalProcess | positive regulation of microtubule polymerization | 8.78e-04 | 37 | 105 | 3 | GO:0031116 | |
| GeneOntologyBiologicalProcess | release of sequestered calcium ion into cytosol by sarcoplasmic reticulum | 8.78e-04 | 37 | 105 | 3 | GO:0014808 | |
| GeneOntologyBiologicalProcess | mitochondrion-endoplasmic reticulum membrane tethering | 9.03e-04 | 9 | 105 | 2 | GO:1990456 | |
| GeneOntologyBiologicalProcess | regulation of voltage-gated calcium channel activity | 9.50e-04 | 38 | 105 | 3 | GO:1901385 | |
| GeneOntologyBiologicalProcess | myofibril assembly | 9.77e-04 | 86 | 105 | 4 | GO:0030239 | |
| GeneOntologyBiologicalProcess | positive regulation of calcium ion transmembrane transporter activity | 1.03e-03 | 39 | 105 | 3 | GO:1901021 | |
| GeneOntologyBiologicalProcess | release of sequestered calcium ion into cytosol by endoplasmic reticulum | 1.03e-03 | 39 | 105 | 3 | GO:1903514 | |
| GeneOntologyBiologicalProcess | lysosomal transport | 1.06e-03 | 151 | 105 | 5 | GO:0007041 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | 1.11e-03 | 313 | 105 | 7 | GO:0098742 | |
| GeneOntologyBiologicalProcess | postsynapse organization | 1.11e-03 | 313 | 105 | 7 | GO:0099173 | |
| GeneOntologyBiologicalProcess | neural crest cell development | 1.11e-03 | 89 | 105 | 4 | GO:0014032 | |
| GeneOntologyBiologicalProcess | negative regulation of protein depolymerization | 1.11e-03 | 89 | 105 | 4 | GO:1901880 | |
| GeneOntologyBiologicalProcess | striated muscle cell development | 1.11e-03 | 89 | 105 | 4 | GO:0055002 | |
| GeneOntologyBiologicalProcess | negative regulation of calcium ion transmembrane transporter activity | 1.19e-03 | 41 | 105 | 3 | GO:1901020 | |
| GeneOntologyBiologicalProcess | 'de novo' post-translational protein folding | 1.19e-03 | 41 | 105 | 3 | GO:0051084 | |
| GeneOntologyBiologicalProcess | cellular response to interferon-beta | 1.19e-03 | 41 | 105 | 3 | GO:0035458 | |
| GeneOntologyBiologicalProcess | negative regulation of protein polymerization | 1.21e-03 | 91 | 105 | 4 | GO:0032272 | |
| GeneOntologyBiologicalProcess | regulation of organelle organization | WAS IQGAP2 SYNE1 SPTBN1 SPTBN2 OBSL1 CUL7 SIRT1 DRG1 SPTBN4 CELSR1 AVIL DHODH CTNNA2 HSPA1A HSPA1B | 1.21e-03 | 1342 | 105 | 16 | GO:0033043 |
| GeneOntologyBiologicalProcess | regulation of anatomical structure morphogenesis | SEMA3F SYNE1 OBSL1 SEMA3G PLXND1 CUL7 SIRT1 CELSR1 SYNE3 DHODH FGFR4 FGD6 GAB1 SEMA3E | 1.25e-03 | 1090 | 105 | 14 | GO:0022603 |
| GeneOntologyBiologicalProcess | positive regulation of microtubule polymerization or depolymerization | 1.27e-03 | 42 | 105 | 3 | GO:0031112 | |
| GeneOntologyBiologicalProcess | vesicle-mediated transport in synapse | 1.28e-03 | 321 | 105 | 7 | GO:0099003 | |
| GeneOntologyBiologicalProcess | regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway | 1.37e-03 | 11 | 105 | 2 | GO:0070432 | |
| GeneOntologyBiologicalProcess | dichotomous subdivision of an epithelial terminal unit | 1.37e-03 | 11 | 105 | 2 | GO:0060600 | |
| GeneOntologyBiologicalProcess | actomyosin structure organization | 1.41e-03 | 239 | 105 | 6 | GO:0031032 | |
| GeneOntologyBiologicalProcess | mitotic cytokinesis | 1.42e-03 | 95 | 105 | 4 | GO:0000281 | |
| GeneOntologyBiologicalProcess | nucleus localization | 1.46e-03 | 44 | 105 | 3 | GO:0051647 | |
| GeneOntologyBiologicalProcess | regulation of mitotic spindle organization | 1.46e-03 | 44 | 105 | 3 | GO:0060236 | |
| GeneOntologyBiologicalProcess | sarcoplasmic reticulum calcium ion transport | 1.46e-03 | 44 | 105 | 3 | GO:0070296 | |
| GeneOntologyCellularComponent | glutamatergic synapse | SEMA3F KIF21B SPTBN1 SPTBN2 LAMA5 MPDZ ADGRL1 NBEA PLXND1 GRM1 CSMD2 TRIM3 AP2B1 CAMKV SNX27 TANC1 HSPA8 | 8.41e-07 | 817 | 107 | 17 | GO:0098978 |
| GeneOntologyCellularComponent | anchoring junction | DCHS2 WAS SPTBN2 OBSCN OBSL1 MPDZ CRB1 SPTBN4 HAVCR2 HMCN1 PCDHGA12 AVIL CTNNA2 FGFR4 HSPA1A HSPA1B HSPA8 GAB1 | 2.17e-06 | 976 | 107 | 18 | GO:0070161 |
| GeneOntologyCellularComponent | sarcomere | 5.43e-06 | 249 | 107 | 9 | GO:0030017 | |
| GeneOntologyCellularComponent | cell-cell junction | DCHS2 WAS SPTBN2 OBSCN OBSL1 MPDZ CRB1 SPTBN4 HMCN1 PCDHGA12 CTNNA2 FGFR4 GAB1 | 1.03e-05 | 591 | 107 | 13 | GO:0005911 |
| GeneOntologyCellularComponent | spectrin | 1.07e-05 | 9 | 107 | 3 | GO:0008091 | |
| GeneOntologyCellularComponent | myofibril | 1.14e-05 | 273 | 107 | 9 | GO:0030016 | |
| GeneOntologyCellularComponent | postsynapse | KIF21B SYNE1 SPTBN1 SPTBN2 MPDZ NBEA GRM1 CSMD2 TRIM3 TFR2 AP2B1 CAMKV SNX27 TANC1 CTNNA2 UTRN HSPA8 | 1.58e-05 | 1018 | 107 | 17 | GO:0098794 |
| GeneOntologyCellularComponent | M band | 1.84e-05 | 31 | 107 | 4 | GO:0031430 | |
| GeneOntologyCellularComponent | contractile muscle fiber | 1.84e-05 | 290 | 107 | 9 | GO:0043292 | |
| GeneOntologyCellularComponent | membrane protein complex | CALM1 CALM2 CALM3 RPN2 SYNE1 MPDZ ABCB6 ATG14 GRM1 CCDC51 CRB1 TFR2 SYNE3 YKT6 AP1B1 AP2B1 SNX27 CTNNA2 UTRN CNGA4 SLC26A6 | 2.02e-05 | 1498 | 107 | 21 | GO:0098796 |
| GeneOntologyCellularComponent | supramolecular fiber | KIF21B WAS KIF27 CALM1 NEBL IQGAP2 CALM2 CALM3 SYNE1 KRT84 SPTBN1 OBSCN OBSL1 SPTBN4 KRT76 AVIL MYOM2 HSPA8 | 2.86e-05 | 1179 | 107 | 18 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | KIF21B WAS KIF27 CALM1 NEBL IQGAP2 CALM2 CALM3 SYNE1 KRT84 SPTBN1 OBSCN OBSL1 SPTBN4 KRT76 AVIL MYOM2 HSPA8 | 3.12e-05 | 1187 | 107 | 18 | GO:0099081 |
| GeneOntologyCellularComponent | axon | KIF21B CALM1 CALM2 CALM3 SPTBN1 ADGRL1 PLXND1 GRM1 SIRT1 SPTBN4 AVIL PYGB TANC1 CTNNA2 HSPA8 | 4.79e-05 | 891 | 107 | 15 | GO:0030424 |
| GeneOntologyCellularComponent | A band | 1.45e-04 | 52 | 107 | 4 | GO:0031672 | |
| GeneOntologyCellularComponent | 3M complex | 2.57e-04 | 5 | 107 | 2 | GO:1990393 | |
| GeneOntologyCellularComponent | subapical complex | 2.57e-04 | 5 | 107 | 2 | GO:0035003 | |
| GeneOntologyCellularComponent | sperm midpiece | 3.26e-04 | 64 | 107 | 4 | GO:0097225 | |
| GeneOntologyCellularComponent | ficolin-1-rich granule lumen | 4.44e-04 | 124 | 107 | 5 | GO:1904813 | |
| GeneOntologyCellularComponent | cell cortex | 6.46e-04 | 371 | 107 | 8 | GO:0005938 | |
| GeneOntologyCellularComponent | calyx of Held | 8.23e-04 | 36 | 107 | 3 | GO:0044305 | |
| GeneOntologyCellularComponent | spectrin-associated cytoskeleton | 9.13e-04 | 9 | 107 | 2 | GO:0014731 | |
| GeneOntologyCellularComponent | nuclear membrane protein complex | 1.39e-03 | 11 | 107 | 2 | GO:0106083 | |
| GeneOntologyCellularComponent | nuclear membrane microtubule tethering complex | 1.39e-03 | 11 | 107 | 2 | GO:0106094 | |
| GeneOntologyCellularComponent | microtubule organizing center attachment site | 1.39e-03 | 11 | 107 | 2 | GO:0034992 | |
| GeneOntologyCellularComponent | meiotic nuclear membrane microtubule tethering complex | 1.39e-03 | 11 | 107 | 2 | GO:0034993 | |
| GeneOntologyCellularComponent | growth cone | 1.64e-03 | 245 | 107 | 6 | GO:0030426 | |
| GeneOntologyCellularComponent | distal axon | 1.79e-03 | 435 | 107 | 8 | GO:0150034 | |
| GeneOntologyCellularComponent | site of polarized growth | 1.93e-03 | 253 | 107 | 6 | GO:0030427 | |
| GeneOntologyCellularComponent | potassium channel complex | 2.01e-03 | 104 | 107 | 4 | GO:0034705 | |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | KIF21B WAS KIF27 CALM1 IQGAP2 CALM2 CALM3 KRT84 SPTBN4 KRT76 AVIL HSPA8 | 2.17e-03 | 899 | 107 | 12 | GO:0099513 |
| GeneOntologyCellularComponent | plasma membrane protein complex | CALM1 CALM2 CALM3 MPDZ ABCB6 GRM1 CRB1 TFR2 AP2B1 CTNNA2 UTRN | 2.29e-03 | 785 | 107 | 11 | GO:0098797 |
| GeneOntologyCellularComponent | ficolin-1-rich granule | 2.64e-03 | 185 | 107 | 5 | GO:0101002 | |
| GeneOntologyCellularComponent | vesicle membrane | WAS CALM1 IQGAP2 CALM2 CALM3 ABCB6 YKT6 AP1B1 AP2B1 CAMKV SNX27 PCDH7 CNGA4 HSPA8 SLC26A6 | 3.04e-03 | 1325 | 107 | 15 | GO:0012506 |
| GeneOntologyCellularComponent | synaptic membrane | 3.05e-03 | 583 | 107 | 9 | GO:0097060 | |
| GeneOntologyCellularComponent | extrinsic component of presynaptic membrane | 3.76e-03 | 18 | 107 | 2 | GO:0098888 | |
| GeneOntologyCellularComponent | synaptic vesicle | 4.48e-03 | 300 | 107 | 6 | GO:0008021 | |
| GeneOntologyCellularComponent | axon terminus | 4.53e-03 | 210 | 107 | 5 | GO:0043679 | |
| GeneOntologyCellularComponent | endolysosome membrane | 4.64e-03 | 20 | 107 | 2 | GO:0036020 | |
| GeneOntologyCellularComponent | postsynaptic membrane | 4.83e-03 | 405 | 107 | 7 | GO:0045211 | |
| GeneOntologyCellularComponent | intercalated disc | 5.13e-03 | 68 | 107 | 3 | GO:0014704 | |
| GeneOntologyCellularComponent | myelin sheath | 5.20e-03 | 217 | 107 | 5 | GO:0043209 | |
| GeneOntologyCellularComponent | transport vesicle | 5.22e-03 | 519 | 107 | 8 | GO:0030133 | |
| MousePheno | ventricular premature beat | 1.75e-05 | 25 | 89 | 4 | MP:0009732 | |
| Domain | Spectrin | 2.70e-09 | 23 | 106 | 6 | PF00435 | |
| Domain | Spectrin_repeat | 1.24e-08 | 29 | 106 | 6 | IPR002017 | |
| Domain | SPEC | 2.33e-08 | 32 | 106 | 6 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 2.33e-08 | 32 | 106 | 6 | IPR018159 | |
| Domain | ACTININ_2 | 1.66e-07 | 23 | 106 | 5 | PS00020 | |
| Domain | ACTININ_1 | 1.66e-07 | 23 | 106 | 5 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 1.66e-07 | 23 | 106 | 5 | IPR001589 | |
| Domain | Spectrin_bsu | 7.08e-07 | 4 | 106 | 3 | IPR016343 | |
| Domain | CH | 1.82e-06 | 65 | 106 | 6 | SM00033 | |
| Domain | CH | 2.83e-06 | 70 | 106 | 6 | PF00307 | |
| Domain | - | 3.08e-06 | 71 | 106 | 6 | 1.10.418.10 | |
| Domain | CH | 3.62e-06 | 73 | 106 | 6 | PS50021 | |
| Domain | CH-domain | 4.25e-06 | 75 | 106 | 6 | IPR001715 | |
| Domain | ig | 1.28e-05 | 190 | 106 | 8 | PF00047 | |
| Domain | Immunoglobulin | 1.28e-05 | 190 | 106 | 8 | IPR013151 | |
| Domain | PH_dom-spectrin-type | 1.46e-05 | 9 | 106 | 3 | IPR001605 | |
| Domain | - | SEMA3F OBSCN OBSL1 SEMA3G PLXND1 NCR3LG1 TRIM3 HAVCR2 TGM3 HMCN1 MYOM2 FGFR4 BCAM SEMA3E | 2.28e-05 | 663 | 106 | 14 | 2.60.40.10 |
| Domain | IG | SEMA3F OBSCN OBSL1 SEMA3G NCR3LG1 HAVCR2 HMCN1 MYOM2 FGFR4 BCAM SEMA3E | 2.73e-05 | 421 | 106 | 11 | SM00409 |
| Domain | Ig_sub | SEMA3F OBSCN OBSL1 SEMA3G NCR3LG1 HAVCR2 HMCN1 MYOM2 FGFR4 BCAM SEMA3E | 2.73e-05 | 421 | 106 | 11 | IPR003599 |
| Domain | Semap_dom | 2.74e-05 | 31 | 106 | 4 | IPR001627 | |
| Domain | SEMA | 2.74e-05 | 31 | 106 | 4 | PS51004 | |
| Domain | Sema | 2.74e-05 | 31 | 106 | 4 | SM00630 | |
| Domain | Sema | 2.74e-05 | 31 | 106 | 4 | PF01403 | |
| Domain | Clathrin_b-adaptin_app_Ig-like | 3.19e-05 | 2 | 106 | 2 | IPR013037 | |
| Domain | - | 3.19e-05 | 2 | 106 | 2 | 2.60.40.1150 | |
| Domain | Ig-like_fold | SEMA3F OBSCN OBSL1 SEMA3G PLXND1 NCR3LG1 TRIM3 HAVCR2 TGM3 HMCN1 MYOM2 FGFR4 BCAM SEMA3E | 4.53e-05 | 706 | 106 | 14 | IPR013783 |
| Domain | EGF | 5.83e-05 | 235 | 106 | 8 | SM00181 | |
| Domain | LAM_G_DOMAIN | 6.24e-05 | 38 | 106 | 4 | PS50025 | |
| Domain | EGF_CA | 6.88e-05 | 122 | 106 | 6 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 7.53e-05 | 124 | 106 | 6 | IPR001881 | |
| Domain | Laminin_G_2 | 7.65e-05 | 40 | 106 | 4 | PF02210 | |
| Domain | EGF | 8.23e-05 | 126 | 106 | 6 | PF00008 | |
| Domain | EGF-like_dom | 8.73e-05 | 249 | 106 | 8 | IPR000742 | |
| Domain | HSP70 | 9.43e-05 | 16 | 106 | 3 | PF00012 | |
| Domain | AP_complex_bsu_1_2_4 | 9.54e-05 | 3 | 106 | 2 | IPR016342 | |
| Domain | B2-adapt-app_C | 9.54e-05 | 3 | 106 | 2 | PF09066 | |
| Domain | IG_LIKE | SEMA3F OBSCN OBSL1 SEMA3G NCR3LG1 HAVCR2 HMCN1 MYOM2 FGFR4 BCAM SEMA3E | 1.09e-04 | 491 | 106 | 11 | PS50835 |
| Domain | PSI | 1.12e-04 | 44 | 106 | 4 | IPR016201 | |
| Domain | LamG | 1.12e-04 | 44 | 106 | 4 | SM00282 | |
| Domain | HSP70_2 | 1.14e-04 | 17 | 106 | 3 | PS00329 | |
| Domain | HSP70_1 | 1.14e-04 | 17 | 106 | 3 | PS00297 | |
| Domain | HSP70_3 | 1.14e-04 | 17 | 106 | 3 | PS01036 | |
| Domain | PSI | 1.33e-04 | 46 | 106 | 4 | SM00423 | |
| Domain | Ig-like_dom | SEMA3F OBSCN OBSL1 SEMA3G NCR3LG1 HAVCR2 HMCN1 MYOM2 FGFR4 BCAM SEMA3E | 1.34e-04 | 503 | 106 | 11 | IPR007110 |
| Domain | Hsp_70_fam | 1.36e-04 | 18 | 106 | 3 | IPR013126 | |
| Domain | Semaphorin | 1.89e-04 | 20 | 106 | 3 | IPR027231 | |
| Domain | KASH | 1.90e-04 | 4 | 106 | 2 | IPR012315 | |
| Domain | KASH | 1.90e-04 | 4 | 106 | 2 | PS51049 | |
| Domain | B2-adapt-app_C | 1.90e-04 | 4 | 106 | 2 | SM01020 | |
| Domain | KASH | 1.90e-04 | 4 | 106 | 2 | SM01249 | |
| Domain | KASH | 1.90e-04 | 4 | 106 | 2 | PF10541 | |
| Domain | B-adaptin_app_sub_C | 1.90e-04 | 4 | 106 | 2 | IPR015151 | |
| Domain | - | 2.07e-04 | 95 | 106 | 5 | 2.60.120.200 | |
| Domain | ASX_HYDROXYL | 2.63e-04 | 100 | 106 | 5 | PS00010 | |
| Domain | Growth_fac_rcpt_ | 2.64e-04 | 156 | 106 | 6 | IPR009030 | |
| Domain | AP_beta | 3.16e-04 | 5 | 106 | 2 | IPR026739 | |
| Domain | Laminin_G | 3.29e-04 | 58 | 106 | 4 | IPR001791 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 3.44e-04 | 106 | 106 | 5 | IPR000152 | |
| Domain | IGc2 | 3.87e-04 | 235 | 106 | 7 | SM00408 | |
| Domain | Ig_sub2 | 3.87e-04 | 235 | 106 | 7 | IPR003598 | |
| Domain | Beta2_adaptin/TBP_C_dom | 4.72e-04 | 6 | 106 | 2 | IPR012295 | |
| Domain | - | 4.72e-04 | 6 | 106 | 2 | 3.30.310.10 | |
| Domain | EGF_1 | 6.30e-04 | 255 | 106 | 7 | PS00022 | |
| Domain | EGF-like_CS | 7.22e-04 | 261 | 106 | 7 | IPR013032 | |
| Domain | EGF_2 | 7.89e-04 | 265 | 106 | 7 | PS01186 | |
| Domain | Coatomer/calthrin_app_sub_C | 8.74e-04 | 8 | 106 | 2 | IPR009028 | |
| Domain | Alpha_adaptinC2 | 1.12e-03 | 9 | 106 | 2 | PF02883 | |
| Domain | Clathrin_a/b/g-adaptin_app_Ig | 1.12e-03 | 9 | 106 | 2 | IPR008152 | |
| Domain | Alpha_adaptinC2 | 1.12e-03 | 9 | 106 | 2 | SM00809 | |
| Domain | NHL_repeat | 1.39e-03 | 10 | 106 | 2 | IPR001258 | |
| Domain | NHL | 1.39e-03 | 10 | 106 | 2 | PF01436 | |
| Domain | EF-hand_7 | 1.39e-03 | 85 | 106 | 4 | PF13499 | |
| Domain | ARM | 1.51e-03 | 40 | 106 | 3 | SM00185 | |
| Domain | GAIN_dom_N | 1.70e-03 | 11 | 106 | 2 | IPR032471 | |
| Domain | GAIN | 1.70e-03 | 11 | 106 | 2 | PF16489 | |
| Domain | PH | 1.96e-03 | 229 | 106 | 6 | PF00169 | |
| Domain | Coatomer/clathrin_app_Ig-like | 2.03e-03 | 12 | 106 | 2 | IPR013041 | |
| Domain | - | 2.03e-03 | 12 | 106 | 2 | 2.60.34.10 | |
| Domain | HSP70_peptide-bd | 2.03e-03 | 12 | 106 | 2 | IPR029047 | |
| Domain | EGF_3 | 2.23e-03 | 235 | 106 | 6 | PS50026 | |
| Domain | EGF_Ca-bd_CS | 2.27e-03 | 97 | 106 | 4 | IPR018097 | |
| Domain | - | 2.39e-03 | 13 | 106 | 2 | 1.20.1270.10 | |
| Domain | Heat_shock_70_CS | 2.39e-03 | 13 | 106 | 2 | IPR018181 | |
| Domain | HSP70_C | 2.39e-03 | 13 | 106 | 2 | IPR029048 | |
| Domain | Armadillo | 2.40e-03 | 47 | 106 | 3 | IPR000225 | |
| Domain | EGF_CA | 2.44e-03 | 99 | 106 | 4 | PS01187 | |
| Domain | PH_dom-like | 2.95e-03 | 426 | 106 | 8 | IPR011993 | |
| Domain | Clathrin/coatomer_adapt-like_N | 3.19e-03 | 15 | 106 | 2 | IPR002553 | |
| Domain | Adaptin_N | 3.19e-03 | 15 | 106 | 2 | PF01602 | |
| Domain | EF_Hand_1_Ca_BS | 3.23e-03 | 175 | 106 | 5 | IPR018247 | |
| Domain | Cadherin_CS | 3.45e-03 | 109 | 106 | 4 | IPR020894 | |
| Domain | CADHERIN_1 | 3.93e-03 | 113 | 106 | 4 | PS00232 | |
| Domain | Cadherin | 3.93e-03 | 113 | 106 | 4 | PF00028 | |
| Domain | CADHERIN_2 | 4.06e-03 | 114 | 106 | 4 | PS50268 | |
| Domain | - | 4.06e-03 | 114 | 106 | 4 | 2.60.40.60 | |
| Domain | CA | 4.18e-03 | 115 | 106 | 4 | SM00112 | |
| Domain | Cadherin-like | 4.31e-03 | 116 | 106 | 4 | IPR015919 | |
| Domain | Ig_I-set | 4.57e-03 | 190 | 106 | 5 | IPR013098 | |
| Domain | I-set | 4.57e-03 | 190 | 106 | 5 | PF07679 | |
| Domain | Cadherin | 4.58e-03 | 118 | 106 | 4 | IPR002126 | |
| Pathway | WP_GLYCOGEN_SYNTHESIS_AND_DEGRADATION | 2.77e-09 | 40 | 82 | 7 | M39595 | |
| Pathway | REACTOME_GLYCOGEN_BREAKDOWN_GLYCOGENOLYSIS | 1.02e-06 | 14 | 82 | 4 | MM15391 | |
| Pathway | WP_GLYCOGEN_METABOLISM | 1.43e-06 | 34 | 82 | 5 | MM15985 | |
| Pathway | REACTOME_CAMK_IV_MEDIATED_PHOSPHORYLATION_OF_CREB | 1.88e-06 | 5 | 82 | 3 | MM14493 | |
| Pathway | REACTOME_GLYCOGEN_METABOLISM | 3.06e-06 | 18 | 82 | 4 | MM15577 | |
| Pathway | REACTOME_CAM_PDE_1_ACTIVATION | 3.75e-06 | 6 | 82 | 3 | MM14494 | |
| Pathway | REACTOME_ACTIVATION_OF_RAC1_DOWNSTREAM_OF_NMDARS | 3.75e-06 | 6 | 82 | 3 | MM15662 | |
| Pathway | BIOCARTA_CACAM_PATHWAY | 6.53e-06 | 7 | 82 | 3 | MM1357 | |
| Pathway | REACTOME_PROTEIN_METHYLATION | 7.18e-06 | 22 | 82 | 4 | MM15519 | |
| Pathway | REACTOME_METABOLISM_OF_COFACTORS | 1.23e-05 | 25 | 82 | 4 | MM15574 | |
| Pathway | KEGG_INSULIN_SIGNALING_PATHWAY | 1.45e-05 | 137 | 82 | 7 | M18155 | |
| Pathway | BIOCARTA_CACAM_PATHWAY | 1.55e-05 | 9 | 82 | 3 | M3412 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 2.21e-05 | 10 | 82 | 3 | MM15112 | |
| Pathway | REACTOME_TETRAHYDROBIOPTERIN_BH4_SYNTHESIS_RECYCLING_SALVAGE_AND_REGULATION | 2.21e-05 | 10 | 82 | 3 | MM14570 | |
| Pathway | KEGG_MEDICUS_REFERENCE_LYSOSOMAL_CA2_RELEASE | 2.21e-05 | 10 | 82 | 3 | M47954 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_IQGAPS | 2.26e-05 | 29 | 82 | 4 | MM15219 | |
| Pathway | REACTOME_CALCINEURIN_ACTIVATES_NFAT | 3.03e-05 | 11 | 82 | 3 | MM14810 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY | 3.03e-05 | 11 | 82 | 3 | M47958 | |
| Pathway | REACTOME_ENOS_ACTIVATION | 4.02e-05 | 12 | 82 | 3 | MM14817 | |
| Pathway | REACTOME_IONOTROPIC_ACTIVITY_OF_KAINATE_RECEPTORS | 4.02e-05 | 12 | 82 | 3 | MM15142 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_CN_SIGNALING_PATHWAY | 4.02e-05 | 12 | 82 | 3 | M47956 | |
| Pathway | REACTOME_SODIUM_CALCIUM_EXCHANGERS | 5.20e-05 | 13 | 82 | 3 | MM15078 | |
| Pathway | REACTOME_ATTENUATION_PHASE | 5.20e-05 | 13 | 82 | 3 | MM14952 | |
| Pathway | KEGG_LONG_TERM_POTENTIATION | 5.30e-05 | 70 | 82 | 5 | M3115 | |
| Pathway | REACTOME_MEMBRANE_TRAFFICKING | KIF21B KIF27 CALM1 SPTBN1 SPTBN2 MON1B SPTBN4 YKT6 AP1B1 AP2B1 EXOC1 GNS HSPA8 | 6.51e-05 | 630 | 82 | 13 | M11480 |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_EGFR_TO_PLCG_CAMK_SIGNALING_PATHWAY | 6.59e-05 | 14 | 82 | 3 | M47386 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_PDGFR_TO_PLCG_CAMK_SIGNALING_PATHWAY | 6.59e-05 | 14 | 82 | 3 | M47388 | |
| Pathway | REACTOME_REDUCTION_OF_CYTOSOLIC_CA_LEVELS | 6.59e-05 | 14 | 82 | 3 | MM15052 | |
| Pathway | REACTOME_GLYCOGEN_BREAKDOWN_GLYCOGENOLYSIS | 6.59e-05 | 14 | 82 | 3 | M19193 | |
| Pathway | BIOCARTA_PGC1A_PATHWAY | 6.59e-05 | 14 | 82 | 3 | MM1473 | |
| Pathway | WP_G13_SIGNALING_PATHWAY | 7.49e-05 | 39 | 82 | 4 | MM15898 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_PLCG_CAMK_SIGNALING_PATHWAY | 8.21e-05 | 15 | 82 | 3 | M47385 | |
| Pathway | BIOCARTA_PGC1A_PATHWAY | 8.21e-05 | 15 | 82 | 3 | M15181 | |
| Pathway | REACTOME_POST_NMDA_RECEPTOR_ACTIVATION_EVENTS | 8.21e-05 | 15 | 82 | 3 | MM15103 | |
| Pathway | BIOCARTA_NDKDYNAMIN_PATHWAY | 8.21e-05 | 15 | 82 | 3 | MM1387 | |
| Pathway | REACTOME_METABOLISM_OF_NITRIC_OXIDE_NOS3_ACTIVATION_AND_REGULATION | 8.21e-05 | 15 | 82 | 3 | MM14795 | |
| Pathway | REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB | 1.01e-04 | 16 | 82 | 3 | MM14492 | |
| Pathway | BIOCARTA_MEF2D_PATHWAY | 1.01e-04 | 16 | 82 | 3 | MM1483 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_PLCG_CALCINEURIN_SIGNALING_PATHWAY | 1.01e-04 | 16 | 82 | 3 | M47449 | |
| Pathway | WP_RENINANGIOTENSINALDOSTERONE_SYSTEM_RAAS | 1.21e-04 | 44 | 82 | 4 | M39845 | |
| Pathway | BIOCARTA_GCR_PATHWAY | 1.22e-04 | 17 | 82 | 3 | M10066 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PDGF_PDGFR_PLCG_CAMK_SIGNALING_PATHWAY | 1.22e-04 | 17 | 82 | 3 | M47387 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HIV_GP120_TO_CXCR4_GNAQ_PLCB_G_CALCINEURIN | 1.22e-04 | 17 | 82 | 3 | M47560 | |
| Pathway | BIOCARTA_NDKDYNAMIN_PATHWAY | 1.22e-04 | 17 | 82 | 3 | M5940 | |
| Pathway | BIOCARTA_GCR_PATHWAY | 1.22e-04 | 17 | 82 | 3 | MM1372 | |
| Pathway | BIOCARTA_CCR5_PATHWAY | 1.22e-04 | 17 | 82 | 3 | M2349 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BCR_PLCG_CALCINEURIN_SIGNALING_PATHWAY | 1.45e-04 | 18 | 82 | 3 | M47580 | |
| Pathway | BIOCARTA_MEF2D_PATHWAY | 1.45e-04 | 18 | 82 | 3 | M5290 | |
| Pathway | BIOCARTA_CALCINEURIN_PATHWAY | 1.45e-04 | 18 | 82 | 3 | MM1385 | |
| Pathway | BIOCARTA_CALCINEURIN_PATHWAY | 1.45e-04 | 18 | 82 | 3 | M3430 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | KRT84 SPTBN1 SPTBN2 PLXND1 SIRT1 SPTBN4 KRT76 AP2B1 CTNNA2 GAB1 SEMA3E | 1.49e-04 | 502 | 82 | 11 | MM14537 |
| Pathway | BIOCARTA_CCR5_PATHWAY | 1.72e-04 | 19 | 82 | 3 | MM1453 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_US28_TO_GNAQ_PLCB_G_CALCINEURIN_SIGNALING_PATHWAY | 1.72e-04 | 19 | 82 | 3 | M47543 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_CAMK_SIGNALING_PATHWAY | 1.72e-04 | 19 | 82 | 3 | M47957 | |
| Pathway | BIOCARTA_NOS1_PATHWAY | 2.01e-04 | 20 | 82 | 3 | MM1445 | |
| Pathway | BIOCARTA_NOS1_PATHWAY | 2.34e-04 | 21 | 82 | 3 | M11650 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CXCR4_GNAQ_PLCB_G_CALCINEURIN_SIGNALING_PATHWAY | 2.34e-04 | 21 | 82 | 3 | M47542 | |
| Pathway | REACTOME_VESICLE_MEDIATED_TRANSPORT | KIF21B KIF27 CALM1 SPTBN1 SPTBN2 MON1B SPTBN4 YKT6 AP1B1 AP2B1 EXOC1 GNS HSPA8 | 2.64e-04 | 725 | 82 | 13 | M27507 |
| Pathway | REACTOME_UNBLOCKING_OF_NMDA_RECEPTORS_GLUTAMATE_BINDING_AND_ACTIVATION | 2.70e-04 | 22 | 82 | 3 | MM15104 | |
| Pathway | REACTOME_HSF1_DEPENDENT_TRANSACTIVATION | 3.09e-04 | 23 | 82 | 3 | MM14953 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_ATP2B3_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 3.09e-04 | 23 | 82 | 3 | M47512 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_PAKS | 3.09e-04 | 23 | 82 | 3 | MM15222 | |
| Pathway | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | 3.32e-04 | 57 | 82 | 4 | MM15643 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_CACNA1D_H_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 3.52e-04 | 24 | 82 | 3 | M47509 | |
| Pathway | BIOCARTA_HDAC_PATHWAY | 3.98e-04 | 25 | 82 | 3 | M1547 | |
| Pathway | BIOCARTA_VIP_PATHWAY | 3.98e-04 | 25 | 82 | 3 | MM1441 | |
| Pathway | REACTOME_GLYCOGEN_METABOLISM | 3.98e-04 | 25 | 82 | 3 | M27857 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KCNJ5_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 3.98e-04 | 25 | 82 | 3 | M47510 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_ATP1A1_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 3.98e-04 | 25 | 82 | 3 | M47511 | |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 4.29e-04 | 109 | 82 | 5 | MM15074 | |
| Pathway | BIOCARTA_AT1R_PATHWAY | 4.48e-04 | 26 | 82 | 3 | MM1346 | |
| Pathway | BIOCARTA_VIP_PATHWAY | 4.48e-04 | 26 | 82 | 3 | M17941 | |
| Pathway | REACTOME_CA_DEPENDENT_EVENTS | 4.48e-04 | 26 | 82 | 3 | MM14495 | |
| Pathway | BIOCARTA_HDAC_PATHWAY | 4.48e-04 | 26 | 82 | 3 | MM1371 | |
| Pathway | BIOCARTA_PYK2_PATHWAY | 4.48e-04 | 26 | 82 | 3 | MM1431 | |
| Pathway | BIOCARTA_AT1R_PATHWAY | 5.02e-04 | 27 | 82 | 3 | M14899 | |
| Pathway | BIOCARTA_PYK2_PATHWAY | 5.02e-04 | 27 | 82 | 3 | M7739 | |
| Pathway | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | 5.02e-04 | 27 | 82 | 3 | MM15053 | |
| Pathway | KEGG_GLIOMA | 5.50e-04 | 65 | 82 | 4 | M1835 | |
| Pathway | REACTOME_SYNTHESIS_OF_IP3_AND_IP4_IN_THE_CYTOSOL | 5.60e-04 | 28 | 82 | 3 | MM14711 | |
| Pathway | REACTOME_ATTENUATION_PHASE | 5.60e-04 | 28 | 82 | 3 | M27254 | |
| Pathway | BIOCARTA_NO1_PATHWAY | 5.60e-04 | 28 | 82 | 3 | M4383 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 5.60e-04 | 28 | 82 | 3 | M47508 | |
| Pathway | KEGG_CALCIUM_SIGNALING_PATHWAY | 5.90e-04 | 178 | 82 | 6 | M2890 | |
| Pathway | BIOCARTA_BIOPEPTIDES_PATHWAY | 6.21e-04 | 29 | 82 | 3 | MM1356 | |
| Pathway | BIOCARTA_BIOPEPTIDES_PATHWAY | 6.21e-04 | 29 | 82 | 3 | M13494 | |
| Pathway | BIOCARTA_GPCR_PATHWAY | 6.21e-04 | 29 | 82 | 3 | MM1495 | |
| Pathway | WP_MELANOMA | 6.53e-04 | 68 | 82 | 4 | M39811 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 6.53e-04 | 68 | 82 | 4 | MM14968 | |
| Pathway | BIOCARTA_GPCR_PATHWAY | 6.88e-04 | 30 | 82 | 3 | M9664 | |
| Pathway | REACTOME_VEGFR2_MEDIATED_VASCULAR_PERMEABILITY | 6.88e-04 | 30 | 82 | 3 | MM15170 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 6.91e-04 | 121 | 82 | 5 | M872 | |
| Pathway | WP_RAS_SIGNALING | 7.02e-04 | 184 | 82 | 6 | M39764 | |
| Pathway | REACTOME_THE_PHOTOTRANSDUCTION_CASCADE | 7.58e-04 | 31 | 82 | 3 | MM14896 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 7.58e-04 | 31 | 82 | 3 | M877 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | 8.02e-04 | 261 | 82 | 7 | MM15676 | |
| Pathway | KEGG_NEUROTROPHIN_SIGNALING_PATHWAY | 8.30e-04 | 126 | 82 | 5 | M16763 | |
| Pathway | BIOCARTA_BCR_PATHWAY | 8.33e-04 | 32 | 82 | 3 | MM1355 | |
| Pathway | REACTOME_ACTIVATION_OF_KAINATE_RECEPTORS_UPON_GLUTAMATE_BINDING | 8.33e-04 | 32 | 82 | 3 | MM15143 | |
| Pathway | REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE | 8.53e-04 | 73 | 82 | 4 | MM14948 | |
| Pubmed | HK1 IQGAP2 SYNE1 SPTBN1 SPTBN2 ADGRL1 NBEA GRM1 TRIM3 SPTBN4 KRT76 AP1B1 AP2B1 CAMKV SNX27 PYGB EXOC1 TANC1 CTNNA2 ALDH1B1 HSPA1A HSPA1B UTRN HSPA8 | 1.07e-11 | 1431 | 108 | 24 | 37142655 | |
| Pubmed | HK1 PDPR RPN2 SYNE1 SPTBN1 SPTBN2 RCN2 OBSL1 MPDZ SIRT1 DRG1 TXNL1 SYNE3 YKT6 PMPCA SUPT16H DNAJC9 TANC1 HSPA1A HSPA1B PLOD2 PCDH7 HSPA8 GAB1 | 2.36e-11 | 1487 | 108 | 24 | 33957083 | |
| Pubmed | KIF21B CALM1 CALM2 CALM3 SPTBN1 SPTBN4 AP1B1 AP2B1 CAMKV PYGB | 1.01e-10 | 163 | 108 | 10 | 16512683 | |
| Pubmed | KIF21B CALM1 IQGAP2 CALM2 SYNE1 SPTBN1 SPTBN2 MPDZ NBEA GRM1 TRIM3 SPTBN4 AP1B1 AP2B1 CAMKV SUPT16H DNAJC9 CTNNA2 HSPA8 | 1.38e-10 | 963 | 108 | 19 | 28671696 | |
| Pubmed | The tale of the long tail: the cytoplasmic domain of HIV-1 gp41. | 1.71e-10 | 26 | 108 | 6 | 23077317 | |
| Pubmed | 4.39e-10 | 5 | 108 | 4 | 17182002 | ||
| Pubmed | PDPR CALM2 CALM3 RPN2 SPTBN1 SPTBN2 PPP2R3B RCN2 NBEA CUL7 PMPCA SUPT16H SNX27 TANC1 USP1 GCN1 UTRN PCDH7 GAB1 | 5.74e-10 | 1049 | 108 | 19 | 27880917 | |
| Pubmed | HK1 CALM1 IQGAP2 RPN2 RCN2 OBSL1 ATG14 MON1B TGM3 KRT76 SUPT16H GCN1 UTRN | 1.14e-09 | 437 | 108 | 13 | 20562859 | |
| Pubmed | 1.31e-09 | 6 | 108 | 4 | 21299499 | ||
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | HK1 PDPR RPN2 ACO1 SPTBN1 DRG1 TXNL1 TGM3 FCGBP YKT6 AP1B1 SUPT16H DNAJC9 PYGB EXOC1 HSPA1A GCN1 UTRN GNS HSPA8 | 7.34e-09 | 1367 | 108 | 20 | 32687490 |
| Pubmed | 1.16e-08 | 266 | 108 | 10 | 19380743 | ||
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | CALM1 RPN2 KRT84 MPDZ CALML5 SIRT1 TXNL1 TGM3 PMPCA AP2B1 SUPT16H MEPCE SNX27 DDX41 USP1 GCN1 UTRN | 1.40e-08 | 1005 | 108 | 17 | 19615732 |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | CALM1 CALM2 CALM3 SPTBN1 RCN2 LAMA5 TGM3 AP1B1 SNX27 PYGB ALDH1B1 HSPA1A HSPA1B HSPA8 | 1.45e-08 | 647 | 108 | 14 | 26618866 |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | HK1 CALM1 IQGAP2 SPTBN1 SPTBN2 RCN2 MPDZ DRG1 PHKA2 AP1B1 AP2B1 SUPT16H DNAJC9 DDX41 HSPA1A PLOD2 GCN1 HSPA8 | 1.62e-08 | 1149 | 108 | 18 | 35446349 |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | IQGAP2 SYNE1 SPTBN1 SPTBN2 NBEA GRM1 AP1B1 AP2B1 CTNNA2 PCDH7 | 1.95e-08 | 281 | 108 | 10 | 28706196 |
| Pubmed | 2.07e-08 | 147 | 108 | 8 | 16959763 | ||
| Pubmed | Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways. | HK1 CALM1 CALM2 CALM3 ACO1 SPTBN1 OBSCN RCN2 KRT76 DHODH EXOC1 GCN1 HSPA8 | 2.36e-08 | 564 | 108 | 13 | 21565611 |
| Pubmed | 2.91e-08 | 3 | 108 | 3 | 29932249 | ||
| Pubmed | 2.91e-08 | 3 | 108 | 3 | 18370588 | ||
| Pubmed | Structural organization of the human CaMIII calmodulin gene. | 2.91e-08 | 3 | 108 | 3 | 2223880 | |
| Pubmed | Molecular mechanisms of calmodulin's functional versatility. | 2.91e-08 | 3 | 108 | 3 | 9923700 | |
| Pubmed | 2.91e-08 | 3 | 108 | 3 | 9681195 | ||
| Pubmed | Allosteric mechanism of water-channel gating by Ca2+-calmodulin. | 2.91e-08 | 3 | 108 | 3 | 23893133 | |
| Pubmed | Expression of HIV-1 envelope glycoprotein alters cellular calmodulin. | 2.91e-08 | 3 | 108 | 3 | 8573130 | |
| Pubmed | 2.91e-08 | 3 | 108 | 3 | 10899953 | ||
| Pubmed | Fluorescent indicators for Ca2+ based on green fluorescent proteins and calmodulin. | 2.91e-08 | 3 | 108 | 3 | 9278050 | |
| Pubmed | 2.91e-08 | 3 | 108 | 3 | 15719022 | ||
| Pubmed | Nef of HIV-1 interacts directly with calcium-bound calmodulin. | 2.91e-08 | 3 | 108 | 3 | 11847276 | |
| Pubmed | 2.91e-08 | 3 | 108 | 3 | 10416864 | ||
| Pubmed | 2.91e-08 | 3 | 108 | 3 | 7828884 | ||
| Pubmed | 2.91e-08 | 3 | 108 | 3 | 8862395 | ||
| Pubmed | Increase of Hspa1a and Hspa1b genes in the resting B cells of Sirt1 knockout mice. | 2.91e-08 | 3 | 108 | 3 | 31102152 | |
| Pubmed | Calmodulin is required for cell-cycle progression during G1 and mitosis. | 2.91e-08 | 3 | 108 | 3 | 2469574 | |
| Pubmed | 2.91e-08 | 3 | 108 | 3 | 23352621 | ||
| Pubmed | Myristoyl moiety of HIV Nef is involved in regulation of the interaction with calmodulin in vivo. | 2.91e-08 | 3 | 108 | 3 | 15632291 | |
| Pubmed | Stored of Hsp72/Hsp73 in germinal vesicle-stage mouse oocytes. | 2.91e-08 | 3 | 108 | 3 | 15129916 | |
| Pubmed | Blocking the Ca2+-induced conformational transitions in calmodulin with disulfide bonds. | 2.91e-08 | 3 | 108 | 3 | 8631777 | |
| Pubmed | 2.91e-08 | 3 | 108 | 3 | 18553937 | ||
| Pubmed | 2.91e-08 | 3 | 108 | 3 | 14978283 | ||
| Pubmed | Calmodulin and HIV type 1: interactions with Gag and Gag products. | 2.91e-08 | 3 | 108 | 3 | 11054265 | |
| Pubmed | 2.91e-08 | 3 | 108 | 3 | 33191766 | ||
| Pubmed | 2.91e-08 | 3 | 108 | 3 | 18940602 | ||
| Pubmed | 2.91e-08 | 3 | 108 | 3 | 25268113 | ||
| Pubmed | 2.91e-08 | 3 | 108 | 3 | 19651602 | ||
| Pubmed | 2.91e-08 | 3 | 108 | 3 | 26969752 | ||
| Pubmed | 2.91e-08 | 3 | 108 | 3 | 8314583 | ||
| Pubmed | Structural basis for the activation of anthrax adenylyl cyclase exotoxin by calmodulin. | 2.91e-08 | 3 | 108 | 3 | 11807546 | |
| Pubmed | 2.91e-08 | 3 | 108 | 3 | 8312049 | ||
| Pubmed | 2.91e-08 | 3 | 108 | 3 | 37380439 | ||
| Pubmed | 2.91e-08 | 3 | 108 | 3 | 31628181 | ||
| Pubmed | 2.91e-08 | 3 | 108 | 3 | 28025138 | ||
| Pubmed | Sequence homology of the 3'-untranslated region of calmodulin III in mammals. | 2.91e-08 | 3 | 108 | 3 | 11710561 | |
| Pubmed | 2.91e-08 | 3 | 108 | 3 | 2445749 | ||
| Pubmed | Signal peptide fragments of preprolactin and HIV-1 p-gp160 interact with calmodulin. | 2.91e-08 | 3 | 108 | 3 | 9362478 | |
| Pubmed | The abundance of calmodulin mRNAs is regulated in phosphorylase kinase-deficient skeletal muscle. | 2.91e-08 | 3 | 108 | 3 | 3384819 | |
| Pubmed | 2.91e-08 | 3 | 108 | 3 | 21799007 | ||
| Pubmed | Binding of calmodulin to the HIV-1 matrix protein triggers myristate exposure. | 2.91e-08 | 3 | 108 | 3 | 20956522 | |
| Pubmed | Noncanonical binding of calmodulin to aquaporin-0: implications for channel regulation. | 2.91e-08 | 3 | 108 | 3 | 18786401 | |
| Pubmed | 2.91e-08 | 3 | 108 | 3 | 11072229 | ||
| Pubmed | 2.91e-08 | 3 | 108 | 3 | 16229872 | ||
| Pubmed | 2.91e-08 | 3 | 108 | 3 | 15063758 | ||
| Pubmed | 2.91e-08 | 3 | 108 | 3 | 8226798 | ||
| Pubmed | 2.91e-08 | 3 | 108 | 3 | 9658102 | ||
| Pubmed | The ankyrin repeats of TRPV1 bind multiple ligands and modulate channel sensitivity. | 2.91e-08 | 3 | 108 | 3 | 17582331 | |
| Pubmed | Integration of repulsive guidance cues generates avascular zones that shape mammalian blood vessels. | 4.19e-08 | 31 | 108 | 5 | 22076636 | |
| Pubmed | The midnolin-proteasome pathway catches proteins for ubiquitination-independent degradation. | HK1 CALM1 RPN2 SPTBN1 SPTBN2 NCR3LG1 PHKA2 AP2B1 SUPT16H DDX41 HSPA1A HSPA8 SLC26A6 | 5.25e-08 | 604 | 108 | 13 | 37616343 |
| Pubmed | CALM1 CALM2 RPN2 SYNE1 RCN2 CALML5 TGM3 HMCN1 AP2B1 PYGB CTNNA2 HSPA1A GCN1 UTRN HSPA8 | 5.68e-08 | 844 | 108 | 15 | 25963833 | |
| Pubmed | Functional specialization of beta-arrestin interactions revealed by proteomic analysis. | CALM1 CALM2 CALM3 RPN2 SPTBN1 LRP1B PHKA2 AP2B1 HSPA1B HSPA8 | 6.04e-08 | 317 | 108 | 10 | 17620599 |
| Pubmed | Proteomics analysis identifies phosphorylation-dependent alpha-synuclein protein interactions. | 8.39e-08 | 176 | 108 | 8 | 18614564 | |
| Pubmed | RPN2 KRT84 RCN2 PUSL1 CALML5 DRG1 TGM3 KRT76 AP1B1 AP2B1 SUPT16H MEPCE DNAJC9 FGFR4 ALDH1B1 DDX41 HSPA8 | 1.01e-07 | 1153 | 108 | 17 | 29845934 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | IRF2BP2 HK1 ACO1 SPTBN1 RCN2 SIRT1 TXNL1 AP1B1 AP2B1 SUPT16H MEPCE PYGB SMS ALDH1B1 HSPA1A PLOD2 GCN1 GNS HSPA8 | 1.09e-07 | 1455 | 108 | 19 | 22863883 |
| Pubmed | A calmodulin-binding sequence in the C-terminus of human cardiac titin kinase. | 1.16e-07 | 4 | 108 | 3 | 7607248 | |
| Pubmed | 1.16e-07 | 4 | 108 | 3 | 27516456 | ||
| Pubmed | 1.16e-07 | 4 | 108 | 3 | 30842726 | ||
| Pubmed | Mutations in calmodulin cause ventricular tachycardia and sudden cardiac death. | 1.16e-07 | 4 | 108 | 3 | 23040497 | |
| Pubmed | 1.16e-07 | 4 | 108 | 3 | 16299511 | ||
| Pubmed | 1.16e-07 | 4 | 108 | 3 | 25437912 | ||
| Pubmed | 1.16e-07 | 4 | 108 | 3 | 17046994 | ||
| Pubmed | A network of control mediated by regulator of calcium/calmodulin-dependent signaling. | 1.16e-07 | 4 | 108 | 3 | 15499021 | |
| Pubmed | 1.16e-07 | 4 | 108 | 3 | 10692436 | ||
| Pubmed | 1.16e-07 | 4 | 108 | 3 | 16478480 | ||
| Pubmed | 1.16e-07 | 4 | 108 | 3 | 21167176 | ||
| Pubmed | Calcium/calmodulin regulates ubiquitination of the ubiquitin-specific protease TRE17/USP6. | 1.16e-07 | 4 | 108 | 3 | 16127172 | |
| Pubmed | 1.16e-07 | 4 | 108 | 3 | 20226167 | ||
| Pubmed | Association analysis of heat shock protein 70 gene polymorphisms in schizophrenia. | 1.16e-07 | 4 | 108 | 3 | 18299791 | |
| Pubmed | 1.16e-07 | 4 | 108 | 3 | 10823944 | ||
| Pubmed | Calm1 signaling pathway is essential for the migration of mouse precerebellar neurons. | 1.16e-07 | 4 | 108 | 3 | 25519244 | |
| Pubmed | Endogenous calmodulin interacts with the epidermal growth factor receptor in living cells. | 1.16e-07 | 4 | 108 | 3 | 14960328 | |
| Pubmed | 1.16e-07 | 4 | 108 | 3 | 22405011 | ||
| Pubmed | 1.16e-07 | 4 | 108 | 3 | 11736632 | ||
| Pubmed | Activation mechanism of a human SK-calmodulin channel complex elucidated by cryo-EM structures. | 1.16e-07 | 4 | 108 | 3 | 29724949 | |
| Pubmed | A calcium sensor in the sodium channel modulates cardiac excitability. | 1.16e-07 | 4 | 108 | 3 | 11807557 | |
| Pubmed | 1.16e-07 | 4 | 108 | 3 | 11286509 | ||
| Pubmed | 1.16e-07 | 4 | 108 | 3 | 20953164 | ||
| Pubmed | 1.16e-07 | 4 | 108 | 3 | 19855925 | ||
| Pubmed | Calmodulin binding to the Fas death domain. Regulation by Fas activation. | 1.16e-07 | 4 | 108 | 3 | 14594800 | |
| Pubmed | Structure of calmodulin bound to the hydrophobic IQ domain of the cardiac Ca(v)1.2 calcium channel. | 1.16e-07 | 4 | 108 | 3 | 16338416 | |
| Pubmed | Role of calmodulin in HIV-potentiated Fas-mediated apoptosis. | 1.16e-07 | 4 | 108 | 3 | 8780394 | |
| Pubmed | Delayed temporal increase of hepatic Hsp70 in ApoE knockout mice after prenatal arsenic exposure. | 1.16e-07 | 4 | 108 | 3 | 22956628 | |
| Pubmed | 1.16e-07 | 4 | 108 | 3 | 19279214 | ||
| Interaction | PCNT interactions | CALM1 CALM2 CALM3 SYNE1 SPTBN1 SPTBN2 NAP1L2 OBSL1 TXNL1 SYNE3 AP2B1 EXOC1 UTRN | 5.58e-10 | 241 | 108 | 13 | int:PCNT |
| Interaction | CFTR interactions | HK1 CALM1 CALM2 CALM3 KRT84 SPTBN1 RCN2 LAMA5 CALML5 CCDC51 TFR2 DRG1 TGM3 AP1B1 AP2B1 CAMKV SUPT16H SNX27 PYGB ALDH1B1 DDX41 HSPA1A HSPA1B GCN1 HSPA8 SEMA3E | 5.06e-08 | 1480 | 108 | 26 | int:CFTR |
| Interaction | RYK interactions | CALM3 CALML5 NCR3LG1 CELSR1 PCDHGA12 CTNNA2 FGFR4 BCAM HSPA1B PCDH7 | 2.12e-07 | 212 | 108 | 10 | int:RYK |
| Interaction | PDIA3 interactions | CALM1 RPN2 OBSL1 CUL7 SYNE3 SLC20A2 SMS FGFR4 ALDH1B1 HSPA1A HSPA1B PLOD2 PCDH7 HSPA8 | 2.56e-07 | 476 | 108 | 14 | int:PDIA3 |
| Interaction | RHOJ interactions | WAS IQGAP2 SPTBN1 SPTBN2 OBSL1 ADGRL1 CUL7 YKT6 SLC20A2 SUPT16H TANC1 PLOD2 UTRN PCDH7 SLC26A6 GAB1 | 2.59e-07 | 633 | 108 | 16 | int:RHOJ |
| Interaction | PPEF1 interactions | 3.43e-07 | 52 | 108 | 6 | int:PPEF1 | |
| Interaction | PPEF2 interactions | 4.32e-07 | 29 | 108 | 5 | int:PPEF2 | |
| Interaction | RAC1 interactions | WAS CALM1 IQGAP2 CALM2 RPN2 SPTBN1 SPTBN2 ADGRL1 YKT6 AP1B1 AP2B1 SLC20A2 TANC1 HSPA1A PLOD2 UTRN PCDH7 HSPA8 SLC26A6 GAB1 | 8.15e-07 | 1063 | 108 | 20 | int:RAC1 |
| Interaction | LAMTOR1 interactions | IQGAP2 SPTBN1 SPTBN2 OBSL1 NBEA DRG1 YKT6 AP1B1 AP2B1 SLC20A2 SNX27 HSPA1A FGD6 PCDH7 HSPA8 GAB1 | 1.47e-06 | 722 | 108 | 16 | int:LAMTOR1 |
| Interaction | EZR interactions | NEBL OBSL1 NBEA CUL7 YKT6 SNX27 TANC1 FGFR4 USP1 HSPA1A UTRN PCDH7 HSPA8 GAB1 | 1.53e-06 | 553 | 108 | 14 | int:EZR |
| Interaction | CUL4B interactions | WAS CALM1 CALM2 CALM3 LRP1B SIRT1 PHKA2 KRT76 SUPT16H TMCO3 BCAM HSPA1A HSPA1B PLOD2 HSPA8 GAB1 | 1.64e-06 | 728 | 108 | 16 | int:CUL4B |
| Interaction | DIABLO interactions | 1.86e-06 | 269 | 108 | 10 | int:DIABLO | |
| Interaction | LRPPRC interactions | HK1 PDPR WAS CALM1 IQGAP2 CALM2 CALM3 SPTBN1 RCN2 CUL7 SIRT1 RCC1L PMPCA MEPCE HSPA1A HSPA8 GAB1 | 1.86e-06 | 827 | 108 | 17 | int:LRPPRC |
| Interaction | CAMKK2 interactions | 1.88e-06 | 69 | 108 | 6 | int:CAMKK2 | |
| Interaction | AGAP2 interactions | 1.96e-06 | 210 | 108 | 9 | int:AGAP2 | |
| Interaction | CTNNA1 interactions | NEBL RPN2 SPTBN1 OBSL1 CUL7 TXNL1 YKT6 SNX27 CTNNA2 UTRN HSPA8 | 2.62e-06 | 347 | 108 | 11 | int:CTNNA1 |
| Interaction | GCHFR interactions | 2.84e-06 | 19 | 108 | 4 | int:GCHFR | |
| Interaction | PODXL interactions | 3.32e-06 | 76 | 108 | 6 | int:PODXL | |
| Interaction | KCTD13 interactions | HK1 IQGAP2 SYNE1 SPTBN1 SPTBN2 ADGRL1 NBEA GRM1 TRIM3 SPTBN4 AP1B1 AP2B1 CAMKV SNX27 PYGB EXOC1 TANC1 CTNNA2 ALDH1B1 HSPA1A UTRN HSPA8 | 3.91e-06 | 1394 | 108 | 22 | int:KCTD13 |
| Interaction | MARCKS interactions | HK1 CALM1 CALM2 CALM3 RPN2 SPTBN1 SPTBN2 YKT6 AP1B1 SLC20A2 PLOD2 UTRN PCDH7 GAB1 | 4.01e-06 | 601 | 108 | 14 | int:MARCKS |
| Interaction | ACO1 interactions | 4.63e-06 | 46 | 108 | 5 | int:ACO1 | |
| Interaction | SPATA17 interactions | 5.16e-06 | 7 | 108 | 3 | int:SPATA17 | |
| Interaction | BAP1 interactions | HK1 CALM1 IQGAP2 KDM5C SPTBN1 SPTBN2 RCN2 MPDZ DRG1 PHKA2 AP1B1 AP2B1 DHODH SUPT16H DNAJC9 SMS DDX41 HSPA1A PLOD2 GCN1 HSPA8 | 5.57e-06 | 1314 | 108 | 21 | int:BAP1 |
| Interaction | DLGAP1 interactions | 5.70e-06 | 180 | 108 | 8 | int:DLGAP1 | |
| Interaction | CFAP298 interactions | 6.39e-06 | 85 | 108 | 6 | int:CFAP298 | |
| Interaction | TNIK interactions | SYNE1 SPTBN1 SPTBN2 NBEA TRIM3 AP2B1 CAMKV SUPT16H CTNNA2 FGFR4 HSPA1A | 6.39e-06 | 381 | 108 | 11 | int:TNIK |
| Interaction | CLTB interactions | 6.98e-06 | 185 | 108 | 8 | int:CLTB | |
| Interaction | CIT interactions | KIF27 CALM1 RPN2 SYNE1 SPTBN1 SPTBN2 RCN2 OBSL1 PLXND1 CUL7 DRG1 SPTBN4 AP2B1 SUPT16H MEPCE DNAJC9 SNX27 MYOM2 DDX41 PLOD2 GCN1 HSPA8 | 7.35e-06 | 1450 | 108 | 22 | int:CIT |
| Interaction | KCNN1 interactions | 8.22e-06 | 8 | 108 | 3 | int:KCNN1 | |
| Interaction | ARPP21 interactions | 8.22e-06 | 8 | 108 | 3 | int:ARPP21 | |
| Interaction | LAMC1 interactions | 8.23e-06 | 135 | 108 | 7 | int:LAMC1 | |
| Interaction | KRT17 interactions | 8.63e-06 | 252 | 108 | 9 | int:KRT17 | |
| Interaction | PHKG2 interactions | 9.49e-06 | 91 | 108 | 6 | int:PHKG2 | |
| Interaction | ATP2B4 interactions | 1.06e-05 | 196 | 108 | 8 | int:ATP2B4 | |
| Interaction | CCDC117 interactions | 1.06e-05 | 26 | 108 | 4 | int:CCDC117 | |
| Interaction | DDX39B interactions | CALM1 RPN2 KRT84 SPTBN1 OBSL1 CUL7 CALML5 TXNL1 TGM3 SUPT16H HSPA1A PCDH7 HSPA8 | 1.14e-05 | 570 | 108 | 13 | int:DDX39B |
| Interaction | DIRAS3 interactions | 1.18e-05 | 262 | 108 | 9 | int:DIRAS3 | |
| Interaction | NEB interactions | 1.37e-05 | 97 | 108 | 6 | int:NEB | |
| Interaction | RHOF interactions | SPTBN1 SPTBN2 MPDZ ADGRL1 KTI12 YKT6 SLC20A2 SUPT16H TANC1 HSPA1A UTRN PCDH7 SLC26A6 GAB1 | 1.45e-05 | 673 | 108 | 14 | int:RHOF |
| Interaction | DCTN1 interactions | NEBL RPN2 KRT84 SPTBN1 SPTBN2 TXNL1 KRT76 SUPT16H MEPCE SNX27 HSPA1A HSPA8 | 1.45e-05 | 497 | 108 | 12 | int:DCTN1 |
| Interaction | ARF6 interactions | HK1 IQGAP2 SPTBN1 SPTBN2 OBSL1 YKT6 AP1B1 AP2B1 SLC20A2 MEPCE SNX27 PCDH7 SLC26A6 | 1.48e-05 | 584 | 108 | 13 | int:ARF6 |
| Interaction | MCM2 interactions | CALM1 CALM2 RPN2 SYNE1 RCN2 OBSL1 CALML5 TGM3 HMCN1 AP2B1 SUPT16H DNAJC9 PYGB CTNNA2 HSPA1A GCN1 UTRN HSPA8 | 1.67e-05 | 1081 | 108 | 18 | int:MCM2 |
| Interaction | DEK interactions | 1.70e-05 | 209 | 108 | 8 | int:DEK | |
| Interaction | IQCG interactions | 1.75e-05 | 10 | 108 | 3 | int:IQCG | |
| Interaction | LTK interactions | 1.78e-05 | 152 | 108 | 7 | int:LTK | |
| Interaction | RHOA interactions | HK1 RPN2 SPTBN1 SPTBN2 ADGRL1 YKT6 SLC20A2 SUPT16H CTNNA2 ALDH1B1 HSPA1A PLOD2 GCN1 UTRN PCDH7 GNS HSPA8 SLC26A6 GAB1 | 1.88e-05 | 1199 | 108 | 19 | int:RHOA |
| Interaction | SH3BP5 interactions | 1.92e-05 | 30 | 108 | 4 | int:SH3BP5 | |
| Interaction | CLTA interactions | 1.93e-05 | 351 | 108 | 10 | int:CLTA | |
| Interaction | EPHA7 interactions | 2.11e-05 | 282 | 108 | 9 | int:EPHA7 | |
| Interaction | CDC42 interactions | WAS CALM1 IQGAP2 CALM2 CALM3 RPN2 ACO1 SYNE1 SPTBN1 SPTBN2 ADGRL1 CALML5 TXNL1 YKT6 SLC20A2 HSPA1A PLOD2 UTRN PCDH7 SLC26A6 | 2.17e-05 | 1323 | 108 | 20 | int:CDC42 |
| Interaction | ACE2 interactions | CALM1 CALM2 RPN2 SPTBN1 LAMA5 NBEA CALML5 ATP10D DRG1 YKT6 AP1B1 SUPT16H DNAJC9 SNX27 HSPA1A HSPA1B GCN1 HSPA8 | 2.26e-05 | 1106 | 108 | 18 | int:ACE2 |
| Interaction | LATS2 interactions | 2.56e-05 | 289 | 108 | 9 | int:LATS2 | |
| Interaction | PLOD1 interactions | 2.78e-05 | 292 | 108 | 9 | int:PLOD1 | |
| Interaction | AXL interactions | 2.96e-05 | 369 | 108 | 10 | int:AXL | |
| Interaction | IQCB1 interactions | 3.02e-05 | 370 | 108 | 10 | int:IQCB1 | |
| Interaction | MIDN interactions | HK1 CALM1 RPN2 SPTBN1 SPTBN2 NCR3LG1 PHKA2 AP2B1 SUPT16H DDX41 HSPA1A HSPA8 SLC26A6 | 3.05e-05 | 626 | 108 | 13 | int:MIDN |
| Interaction | ARRB2 interactions | CALM3 RPN2 SPTBN1 GRM1 SIRT1 PHKA2 AP1B1 AP2B1 CAMKV HSPA1B HSPA8 | 3.25e-05 | 454 | 108 | 11 | int:ARRB2 |
| Interaction | TTN interactions | 3.34e-05 | 299 | 108 | 9 | int:TTN | |
| Interaction | FGFR4 interactions | CALM3 NBEA GRM1 NCR3LG1 YKT6 TANC1 FGFR4 HSPA1B UTRN PCDH7 GAB1 | 3.53e-05 | 458 | 108 | 11 | int:FGFR4 |
| Interaction | NSMF interactions | 3.59e-05 | 35 | 108 | 4 | int:NSMF | |
| Interaction | DNAJC5 interactions | 3.62e-05 | 378 | 108 | 10 | int:DNAJC5 | |
| Interaction | ARHGAP1 interactions | 3.69e-05 | 233 | 108 | 8 | int:ARHGAP1 | |
| Interaction | LCK interactions | WAS SPTBN1 SPTBN2 OBSL1 DRG1 HAVCR2 TANC1 HSPA1A UTRN HSPA8 GAB1 | 3.89e-05 | 463 | 108 | 11 | int:LCK |
| Interaction | WDR76 interactions | CALM3 SPTBN1 RCN2 LAMA5 SIRT1 SUPT16H HSPA1A GCN1 UTRN HSPA8 | 4.05e-05 | 383 | 108 | 10 | int:WDR76 |
| Interaction | LAMP1 interactions | RPN2 SPTBN1 SPTBN2 OBSL1 NBEA NCR3LG1 PHKA2 YKT6 AP2B1 SLC20A2 HSPA1A PCDH7 HSPA8 | 4.08e-05 | 644 | 108 | 13 | int:LAMP1 |
| Interaction | C11orf65 interactions | 4.12e-05 | 13 | 108 | 3 | int:C11orf65 | |
| Interaction | PDIA4 interactions | CALM1 RPN2 SYNE1 RCN2 OBSL1 CUL7 SYNE3 FGFR4 HSPA1A PLOD2 HSPA8 | 4.29e-05 | 468 | 108 | 11 | int:PDIA4 |
| Interaction | DVL2 interactions | WAS SYNE1 ATG14 SIRT1 HMCN1 AP1B1 AP2B1 TANC1 DDX41 HSPA1A HSPA1B HSPA8 | 4.41e-05 | 557 | 108 | 12 | int:DVL2 |
| Interaction | DCLRE1B interactions | 4.50e-05 | 37 | 108 | 4 | int:DCLRE1B | |
| Interaction | C11orf52 interactions | 4.54e-05 | 311 | 108 | 9 | int:C11orf52 | |
| Interaction | SNW1 interactions | KIF27 CALM1 SPTBN1 OBSL1 KTI12 CUL7 SIRT1 DRG1 AP1B1 EXOC1 DDX41 HSPA1A GCN1 HSPA8 | 4.55e-05 | 747 | 108 | 14 | int:SNW1 |
| Interaction | MDH2 interactions | HK1 PDPR CALM1 OBSL1 CUL7 RCC1L YKT6 PMPCA MEPCE DNAJC9 HSPA1A HSPA8 | 4.57e-05 | 559 | 108 | 12 | int:MDH2 |
| Interaction | SPEN interactions | 4.91e-05 | 178 | 108 | 7 | int:SPEN | |
| Interaction | CEP290 interactions | 5.08e-05 | 179 | 108 | 7 | int:CEP290 | |
| Interaction | SYNRG interactions | 5.16e-05 | 75 | 108 | 5 | int:SYNRG | |
| Interaction | HYOU1 interactions | 5.26e-05 | 317 | 108 | 9 | int:HYOU1 | |
| Interaction | GLDC interactions | 5.80e-05 | 321 | 108 | 9 | int:GLDC | |
| Interaction | JUP interactions | CALM1 OBSL1 CUL7 CALML5 CCDC51 CTNNA2 USP1 HSPA1A PLOD2 HSPA8 GAB1 | 5.91e-05 | 485 | 108 | 11 | int:JUP |
| Interaction | CYLD interactions | CALM1 ACO1 KRT84 SPTBN1 RCN2 CALML5 DRG1 TGM3 SYNE3 AP2B1 FGFR4 USP1 HSPA1B GCN1 HSPA8 | 6.01e-05 | 868 | 108 | 15 | int:CYLD |
| Interaction | TFRC interactions | SPTBN1 SPTBN2 NBEA CUL7 TFR2 SYNE3 YKT6 AP2B1 EXOC1 PCDH7 HSPA8 | 6.36e-05 | 489 | 108 | 11 | int:TFRC |
| Interaction | OSCP1 interactions | 6.50e-05 | 15 | 108 | 3 | int:OSCP1 | |
| Interaction | AFDN interactions | 7.68e-05 | 333 | 108 | 9 | int:AFDN | |
| Interaction | OCLN interactions | IQGAP2 SPTBN1 SPTBN2 NBEA SIRT1 YKT6 AP2B1 TANC1 UTRN PCDH7 GAB1 | 7.76e-05 | 500 | 108 | 11 | int:OCLN |
| Interaction | ITSN1 interactions | 7.77e-05 | 259 | 108 | 8 | int:ITSN1 | |
| Interaction | ZNF280A interactions | 7.97e-05 | 16 | 108 | 3 | int:ZNF280A | |
| Interaction | PHKA1 interactions | 8.19e-05 | 43 | 108 | 4 | int:PHKA1 | |
| Interaction | ADRB2 interactions | 8.80e-05 | 339 | 108 | 9 | int:ADRB2 | |
| Interaction | ARFGAP1 interactions | 8.84e-05 | 135 | 108 | 6 | int:ARFGAP1 | |
| Interaction | KCNQ2 interactions | 8.88e-05 | 84 | 108 | 5 | int:KCNQ2 | |
| Interaction | STIP1 interactions | IRF2BP2 RPN2 SPTBN1 RCN2 CUL7 YKT6 AP1B1 AP2B1 SUPT16H ALDH1B1 DDX41 HSPA1A HSPA1B GCN1 PCDH7 HSPA8 | 8.91e-05 | 1006 | 108 | 16 | int:STIP1 |
| Interaction | DTYMK interactions | 8.98e-05 | 44 | 108 | 4 | int:DTYMK | |
| Interaction | IQSEC2 interactions | 8.98e-05 | 44 | 108 | 4 | int:IQSEC2 | |
| Interaction | C2CD4B interactions | 8.98e-05 | 44 | 108 | 4 | int:C2CD4B | |
| Interaction | CALD1 interactions | 9.11e-05 | 265 | 108 | 8 | int:CALD1 | |
| Interaction | DSP interactions | OBSL1 CUL7 CALML5 CCDC51 TGM3 AP1B1 ALDH1B1 HSPA1A HSPA8 GAB1 | 9.26e-05 | 423 | 108 | 10 | int:DSP |
| Interaction | NUDCD2 interactions | 9.44e-05 | 424 | 108 | 10 | int:NUDCD2 | |
| Interaction | H4C11 interactions | 9.81e-05 | 45 | 108 | 4 | int:H4C11 | |
| Interaction | RALB interactions | 9.93e-05 | 86 | 108 | 5 | int:RALB | |
| Interaction | LAMP2 interactions | SPTBN1 SPTBN2 ATG14 NBEA YKT6 AP1B1 AP2B1 SLC20A2 HSPA1A PCDH7 GNS HSPA8 | 1.03e-04 | 609 | 108 | 12 | int:LAMP2 |
| Interaction | HEXIM1 interactions | RPN2 KRT84 PUSL1 CALML5 DRG1 TGM3 KRT76 AP1B1 AP2B1 SUPT16H MEPCE FGFR4 ALDH1B1 DDX41 HSPA8 | 1.06e-04 | 913 | 108 | 15 | int:HEXIM1 |
| Cytoband | 6q24 | 1.52e-04 | 8 | 108 | 2 | 6q24 | |
| GeneFamily | EF-hand domain containing|Spectrins | 2.47e-06 | 7 | 76 | 3 | 1113 | |
| GeneFamily | Heat shock 70kDa proteins | 4.65e-05 | 17 | 76 | 3 | 583 | |
| GeneFamily | Immunoglobulin like domain containing|Semaphorins | 7.73e-05 | 20 | 76 | 3 | 736 | |
| GeneFamily | Spectrin repeat containing nuclear envelope family | 1.04e-04 | 4 | 76 | 2 | 1252 | |
| GeneFamily | Immunoglobulin like domain containing | 1.61e-04 | 193 | 76 | 6 | 594 | |
| GeneFamily | EF-hand domain containing | 3.18e-04 | 219 | 76 | 6 | 863 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 5.84e-04 | 161 | 76 | 5 | 593 | |
| GeneFamily | PDZ domain containing|Crumbs complex | 6.16e-04 | 9 | 76 | 2 | 1223 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.75e-03 | 206 | 76 | 5 | 682 | |
| GeneFamily | Keratins, type II | 5.72e-03 | 27 | 76 | 2 | 609 | |
| Coexpression | DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN | KDM5C SPTBN2 OBSL1 LAMA5 ABCB6 PMPCA MYOM2 ALDH1B1 PCDH7 GNS | 2.23e-07 | 276 | 108 | 10 | M3063 |
| Coexpression | KRISHNAN_FURIN_TARGETS_UP | 7.99e-06 | 10 | 108 | 3 | MM1243 | |
| Coexpression | CUI_TCF21_TARGETS_DN | 1.02e-05 | 33 | 108 | 4 | MM664 | |
| Coexpression | CUI_TCF21_TARGETS_DN | 1.15e-05 | 34 | 108 | 4 | M6937 | |
| Coexpression | DIAZ_CHRONIC_MYELOGENOUS_LEUKEMIA_UP | HK1 CALM1 IQGAP2 RPN2 ACO1 SPTBN2 ABCB6 SIRT1 TFR2 DRG1 TXNL1 YKT6 SUPT16H SMS DDX41 USP1 PLOD2 GNS | 1.59e-05 | 1399 | 108 | 18 | M535 |
| Coexpression | GSE1432_CTRL_VS_IFNG_24H_MICROGLIA_UP | 1.97e-05 | 200 | 108 | 7 | M3407 | |
| Coexpression | IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_DN | 1.99e-05 | 363 | 108 | 9 | M6315 | |
| Coexpression | ZHANG_UTERUS_C6_ENDOTHELIAL_PLVAP_HIGH_CELL | 2.26e-05 | 137 | 108 | 6 | MM16612 | |
| Coexpression | IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_DN | 2.41e-05 | 372 | 108 | 9 | MM1043 | |
| Coexpression | WANG_SMARCE1_TARGETS_UP | 3.04e-05 | 294 | 108 | 8 | M1804 | |
| Coexpression | UEDA_CENTRAL_CLOCK | 3.60e-05 | 90 | 108 | 5 | M2637 | |
| Coexpression | LEE_AGING_MUSCLE_DN | 3.89e-05 | 46 | 108 | 4 | MM670 | |
| Coexpression | UEDA_CENTRAL_CLOCK | 4.22e-05 | 93 | 108 | 5 | MM1141 | |
| Coexpression | RAMPON_ENRICHED_LEARNING_ENVIRONMENT_EARLY_UP | 4.44e-05 | 17 | 108 | 3 | MM686 | |
| Coexpression | LAKE_ADULT_KIDNEY_C26_MESANGIAL_CELLS | 9.43e-05 | 177 | 108 | 6 | M39245 | |
| Coexpression | CHEN_METABOLIC_SYNDROM_NETWORK | WAS CALM1 IQGAP2 CALM2 ADAMTS2 CALM3 OBSL1 SEMA3G HAVCR2 SNX27 SMS TANC1 ALDH1B1 MMP12 FGD6 GNS | 9.65e-05 | 1316 | 108 | 16 | MM1052 |
| Coexpression | TABULA_MURIS_SENIS_TRACHEA_BASAL_EPITHELIAL_CELL_OF_TRACHEOBRONCHIAL_TREE_AGEING | 9.90e-05 | 22 | 108 | 3 | MM3854 | |
| Coexpression | NABA_MATRISOME_PRIMARY_METASTATIC_COLORECTAL_TUMOR | 1.04e-04 | 59 | 108 | 4 | M47989 | |
| Coexpression | RAMPON_ENRICHED_LEARNING_ENVIRONMENT_LATE_UP | 1.13e-04 | 23 | 108 | 3 | MM694 | |
| Coexpression | DESCARTES_FETAL_HEART_SATB2_LRRC7_POSITIVE_CELLS | 1.16e-04 | 115 | 108 | 5 | M40201 | |
| Coexpression | GSE37416_0H_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_UP | 1.65e-04 | 196 | 108 | 6 | M5349 | |
| Coexpression | GSE18281_CORTICAL_THYMOCYTE_VS_WHOLE_CORTEX_THYMUS_UP | 1.65e-04 | 196 | 108 | 6 | M7238 | |
| Coexpression | DEN_INTERACT_WITH_LCA5 | 1.65e-04 | 26 | 108 | 3 | M1380 | |
| Coexpression | FOURNIER_ACINAR_DEVELOPMENT_LATE_2 | 1.67e-04 | 281 | 108 | 7 | M4077 | |
| Coexpression | GSE2770_IL12_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_6H_UP | 1.69e-04 | 197 | 108 | 6 | M6059 | |
| Coexpression | GSE15930_NAIVE_VS_48H_IN_VITRO_STIM_CD8_TCELL_UP | 1.74e-04 | 198 | 108 | 6 | M3596 | |
| Coexpression | GSE37533_UNTREATED_VS_PIOGLIZATONE_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_DN | 1.84e-04 | 200 | 108 | 6 | M9002 | |
| Coexpression | GSE18893_CTRL_VS_TNF_TREATED_TCONV_2H_UP | 1.84e-04 | 200 | 108 | 6 | M7295 | |
| Coexpression | GSE42724_NAIVE_VS_B1_BCELL_UP | 1.84e-04 | 200 | 108 | 6 | M9790 | |
| Coexpression | GSE3982_EOSINOPHIL_VS_TH1_DN | 1.84e-04 | 200 | 108 | 6 | M5423 | |
| Coexpression | FOSTER_KDM1A_TARGETS_DN | 1.94e-04 | 202 | 108 | 6 | M2514 | |
| Coexpression | FOSTER_KDM1A_TARGETS_DN | 2.10e-04 | 205 | 108 | 6 | MM957 | |
| Coexpression | CUI_TCF21_TARGETS_2_DN | IRF2BP2 CALM1 NEBL IQGAP2 CALM2 SEMA3G MYOM2 TANC1 HSPA1A HSPA1B PLOD2 SEMA3E | 2.11e-04 | 854 | 108 | 12 | M1533 |
| Coexpression | CROMER_METASTASIS_UP | 2.38e-04 | 73 | 108 | 4 | M7061 | |
| Coexpression | CUI_TCF21_TARGETS_2_DN | IRF2BP2 CALM1 NEBL IQGAP2 CALM2 SEMA3G MYOM2 TANC1 HSPA1A HSPA1B PLOD2 SEMA3E | 3.00e-04 | 888 | 108 | 12 | MM1018 |
| Coexpression | CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_UP | CALM3 RCN2 SEMA3G PLXND1 CUL7 ATP10D AP2B1 PYGB CTNNA2 BCAM UTRN SLC26A6 | 3.10e-04 | 891 | 108 | 12 | M45033 |
| Coexpression | NABA_MATRISOME | SEMA3F PAMR1 ADAMTS2 LAMA5 C1QL4 SEMA3G PLXND1 TGM3 EYS HMCN1 MMP12 PLOD2 SEMA3E | 3.10e-04 | 1026 | 108 | 13 | M5889 |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon|organoid_Paulsen_bioRxiv / Sample Type, Dataset, Time_group, and Cell type. | 2.84e-08 | 197 | 108 | 8 | a97556e9fbb24272de51f54ecda6ab9ccb97a61e | |
| ToppCell | control|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.19e-08 | 200 | 108 | 8 | 97f36d2c197e03d93a1fc59949d77ae90f6e6a9a | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.17e-07 | 190 | 108 | 7 | 0a351609a72fd638c84b2435782e312ee6a33aac | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer|World / Primary Cells by Cluster | 5.89e-07 | 200 | 108 | 7 | db10f76938af553d1a2275bb02ef75dff3c3135b | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer-21|World / Primary Cells by Cluster | 5.89e-07 | 200 | 108 | 7 | 30a3e4aee12ec1b5acdce90f86c9733c27a7f6fc | |
| ToppCell | metastatic_Brain-Myeloid_cells-mo-Mac|Myeloid_cells / Location, Cell class and cell subclass | 5.89e-07 | 200 | 108 | 7 | bfb54a8ce44caf01083c6567b236395c6ee1d47a | |
| ToppCell | E12.5-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.36e-06 | 143 | 108 | 6 | cc396b81a5e47d78c2d1cb49d682391376b63476 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-Tuft-related-Tuft|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.58e-06 | 169 | 108 | 6 | 05e12524d68d409fed386ffad233305683b4575b | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.02e-06 | 185 | 108 | 6 | bdd2e6cb20294b39a9d856004bf57ba69cf877e2 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1|Adult / Lineage, Cell type, age group and donor | 6.40e-06 | 187 | 108 | 6 | 77f78aec946bc6bd85c29aee9ca978ce49f853a3 | |
| ToppCell | Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)|Adult / Lineage, Cell type, age group and donor | 6.60e-06 | 188 | 108 | 6 | e5cad03f4a64147fe8174e7f614cf45233ffb9b7 | |
| ToppCell | 5'-Adult-LymphNode-Endothelial-blood_vessel_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.01e-06 | 190 | 108 | 6 | 141266bf411ea675fbf889b20c1b08673c45ff95 | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-Tuft-related-Tuft|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.23e-06 | 191 | 108 | 6 | 54f07e4de61735051498846afb44b1798bed8144 | |
| ToppCell | droplet-Heart-nan-18m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.45e-06 | 192 | 108 | 6 | 0bf99e029a06151092db1e8a0dcb45f4e688e771 | |
| ToppCell | droplet-Heart-nan-18m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.45e-06 | 192 | 108 | 6 | d766221acfce30cbf2c60b3ae40f6744968b952c | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 8.14e-06 | 195 | 108 | 6 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | 8.14e-06 | 195 | 108 | 6 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.87e-06 | 198 | 108 | 6 | 72e8b9cccb7b0a2ea9d415218fff4fa2f09728f4 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 8.87e-06 | 198 | 108 | 6 | cc2b5b632e73e44bb60050f0db10d8f0dbb859fa | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.87e-06 | 198 | 108 | 6 | 5374b0e98d669f36a0571d3c006c7bd5e3c8e87f | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_immature|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.13e-06 | 199 | 108 | 6 | 9c40b3ee39860e9d8edafd007daec11abdd95435 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.13e-06 | 199 | 108 | 6 | 94a7867e800df352731796de8c24cba133c29622 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.13e-06 | 199 | 108 | 6 | 72b34bce8157abe389e95cd3ed8ba578dce0cbf6 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Duct|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.40e-06 | 200 | 108 | 6 | b992eeddee38e6fe3564e9b1850f6b20b89bf47d | |
| ToppCell | mLN-Macrophage-LYVE1_Macrophage|Macrophage / Region, Cell class and subclass | 9.40e-06 | 200 | 108 | 6 | e3c15e0e1c2602b0cc9ab8cc50c978d265350c94 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW09-Neuronal-Neurons|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 9.40e-06 | 200 | 108 | 6 | ddac952ad1d46021c2d17d816de9bc31730a0941 | |
| ToppCell | NS-control|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 9.40e-06 | 200 | 108 | 6 | ecbe89ff95d046155b984c8c150e0b9e7278f839 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Neuronal-CPNs|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 9.40e-06 | 200 | 108 | 6 | 71cbefbef4ae5bbb5f6e419914f4b3b3b5a5f9e3 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L5_PT-L5_PT_VISp_C1ql2_Cdh13|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.04e-05 | 136 | 108 | 5 | 1f3000d5f105c87c80f8ae1dd2264bcd7f757a9c | |
| ToppCell | 356C-Epithelial_cells-Epithelial-E_(AT2)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.42e-05 | 141 | 108 | 5 | 31e0984f09983e83a814424f74c871c1c5a3a789 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-E_(AT2)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.42e-05 | 141 | 108 | 5 | d7d3c3932651d90fa4f3c4e3df16f4b677faaf9f | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.05e-05 | 148 | 108 | 5 | d6ac5972267254651dfbe16bb4e9a62228093cc7 | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.47e-05 | 152 | 108 | 5 | d5ba87b5d34e52cef8475befafea962d70fa8a1d | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.47e-05 | 152 | 108 | 5 | d88d68a788a3256671ebbc06e104833f1f58f07d | |
| ToppCell | Adult-Immune-enucleated_erythrocyte-D175|Adult / Lineage, Cell type, age group and donor | 3.47e-05 | 152 | 108 | 5 | 530d5427d8617dcb223d807b73abee0ef89285f3 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_VISp_Batf3|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.05e-05 | 157 | 108 | 5 | 921805932f7974d37aed547861d555b07f30aba6 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 4.84e-05 | 163 | 108 | 5 | 218b9ba099cb27aa91c6b73bf89b44895f5dddc3 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L4|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.84e-05 | 163 | 108 | 5 | 1e8ab00ecc2d2ba35aa6745c0ed38663e26312e8 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L4-L4_IT_VISp_Rspo1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.84e-05 | 163 | 108 | 5 | 431221a41d396b09170476179590eaf8a55266d8 | |
| ToppCell | Sigmoid-Macrophage-Macrophage|Macrophage / Region, Cell class and subclass | 5.59e-05 | 168 | 108 | 5 | bb16e135b6ae0d66615420b61edd6f62f2a3233c | |
| ToppCell | droplet-Heart-4Chambers-21m-Hematologic-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.08e-05 | 171 | 108 | 5 | e852d0e8589eecf4a2e5fea039b52a67c5d58dbd | |
| ToppCell | 3'_v3-lymph-node_spleen-Hematopoietic_progenitors-Progenitor_Erythro-Mega|lymph-node_spleen / Manually curated celltypes from each tissue | 6.08e-05 | 171 | 108 | 5 | 3ecd0a074344179c57eb2d9a857ba594904d00fa | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Endothelial-Hepatocyte_(Pericentral)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.78e-05 | 175 | 108 | 5 | 98dc3b6f69a29d587f503898f09912700950e3d9 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.96e-05 | 176 | 108 | 5 | 0710689e66deba179b0a8038cdd56b4834984f12 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.15e-05 | 177 | 108 | 5 | da8802a6351d3e510822f82e2fde8a4314a2216e | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.15e-05 | 177 | 108 | 5 | f30d757ee8db7e10d547498dab6560473c6ed7c0 | |
| ToppCell | (1)_Control_(PBS)-(2)_LEPR+_perivascular_cells_and_VE-Cad+_vascular_cells_(mixed)|(1)_Control_(PBS) / Stress and Cell class | 7.15e-05 | 177 | 108 | 5 | d9e5ac5b8949a77e88e8094079167e4cf2c1bbd1 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L6_THEMIS_LINC00343|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.35e-05 | 178 | 108 | 5 | 6f61490d79cd1727ed2d5cc673823dd4efdafac1 | |
| ToppCell | Adult-Epithelial-lung_goblet_cell|Adult / Lineage, Cell type, age group and donor | 7.54e-05 | 179 | 108 | 5 | 1fc1f252ca943a2f649d1e627f56acbf15f8e058 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.54e-05 | 179 | 108 | 5 | 1ac79c82c52fa95bb4e170ab20fec0f648db2134 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.54e-05 | 179 | 108 | 5 | 445eeb0356d9fd894aa33dd9f45d893b21424149 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L6_THEMIS_LINC00343|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.95e-05 | 181 | 108 | 5 | 9de2f2cc5f02e0ca599c9e0d2cb1e1e4b5aac112 | |
| ToppCell | facs-Kidney-nan-3m|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.16e-05 | 182 | 108 | 5 | 4c5d14e33ebdf117b5aa9e2f57aaa89aa51f72bf | |
| ToppCell | facs-Liver-Hepatocytes-24m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.37e-05 | 183 | 108 | 5 | d0721c6aa426953a520d40e976b6e65aa7ca65e8 | |
| ToppCell | COPD-Epithelial-Basal|COPD / Disease state, Lineage and Cell class | 8.37e-05 | 183 | 108 | 5 | 0f760e393edc91009bf6c7e02eeac039a1dfb4ed | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.59e-05 | 184 | 108 | 5 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.59e-05 | 184 | 108 | 5 | 9a185e6ea86bbfbb48bfe88650a8c05ceba78d7f | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.59e-05 | 184 | 108 | 5 | 57c792e6e2fedba25d3350ffe649fd74750b579d | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 8.59e-05 | 184 | 108 | 5 | 67164bb6bcae7322cb89b585c7aa10bce35b0ecd | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.59e-05 | 184 | 108 | 5 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 8.59e-05 | 184 | 108 | 5 | 25ccf08a8a26d7e7827b6357f33a53aaf423577d | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.59e-05 | 184 | 108 | 5 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Lung-24m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.59e-05 | 184 | 108 | 5 | d754c3de621429b220ae4ac426cdfc619e848462 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.59e-05 | 184 | 108 | 5 | d7bd0f0c607bade67c99e9fb3578a570298bf926 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D175|Adult / Lineage, Cell type, age group and donor | 8.81e-05 | 185 | 108 | 5 | 32b4e68e551d435a732f253f6ad83408c759a642 | |
| ToppCell | Fetal_29-31_weeks-Immune-enucleated_erythrocyte-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.81e-05 | 185 | 108 | 5 | e8f7da9641b6cf1db1093b4f301ce828fd3a529c | |
| ToppCell | Immune-enucleated_erythrocyte|World / Lineage, Cell type, age group and donor | 9.04e-05 | 186 | 108 | 5 | f9d5ec5cc8fd6e63bf25abe390307ec8a4a2d5a3 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma-chondrocyte|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 9.04e-05 | 186 | 108 | 5 | 80a0a42ca8585cdb1dda57a18c254316a126ee64 | |
| ToppCell | droplet-Heart-nan-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.04e-05 | 186 | 108 | 5 | 0ae5fbe9f210cb25092394267e1d3d6ed05627b8 | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Mesenchymal-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.04e-05 | 186 | 108 | 5 | 4ae3c0fe8640a8d029875cf3f0f5ffbba38e85f8 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.04e-05 | 186 | 108 | 5 | 5302399825f213d105ac70b91366a4513b732838 | |
| ToppCell | severe_influenza-RBC|World / disease group, cell group and cell class (v2) | 9.27e-05 | 187 | 108 | 5 | f846750575f318503d21ade30f5bfd2e1d4c84af | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c05-ZNF683|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.27e-05 | 187 | 108 | 5 | 8c69fd469df2915c56ede534cee3ef23d5f64ebf | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|World / Chamber and Cluster_Paper | 9.27e-05 | 187 | 108 | 5 | 78cdcf8bc141d3b155c3c8af908431fc419c4d08 | |
| ToppCell | Influenza_Severe-RBC|World / Disease group and Cell class | 9.50e-05 | 188 | 108 | 5 | f0438e6a77ee1f0456cb65926685266fff470983 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.50e-05 | 188 | 108 | 5 | 63a4b25a0a6e05f80f1a6dd91b817f3cf49e6b68 | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|RV / Chamber and Cluster_Paper | 9.74e-05 | 189 | 108 | 5 | 9c1debd65c13d63fd4f3158917d621b44b714c26 | |
| ToppCell | droplet-Heart-nan-24m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.74e-05 | 189 | 108 | 5 | 1137583e21d874c201c20581ba1995e2bfa3de59 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 9.74e-05 | 189 | 108 | 5 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D231|Adult / Lineage, Cell type, age group and donor | 9.74e-05 | 189 | 108 | 5 | 5a04cb25f8f0447b2cecdb6c3695029281aca26d | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 9.99e-05 | 190 | 108 | 5 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.99e-05 | 190 | 108 | 5 | b855b8b7d3439023390ca44629c1a99f5d4c6801 | |
| ToppCell | droplet-Heart-nan-24m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.99e-05 | 190 | 108 | 5 | 7068754c29f63a331e2b6c54715f3b26f37ad32b | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.99e-05 | 190 | 108 | 5 | a5db902ad112a0c0a0a7f1a2e38718bb3bd11412 | |
| ToppCell | ILEUM-non-inflamed-(8)_Activated_fibroblasts|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 9.99e-05 | 190 | 108 | 5 | 39fa110d19c97c7cac99f5fb91b26bc08e2f3b42 | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-04 | 191 | 108 | 5 | 97fb4232417a39801e87725755fd16a57c250209 | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-04 | 191 | 108 | 5 | 64070a309d7e3f6001272409ab9ce206d0e7d73f | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference|renal_papilla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 1.05e-04 | 192 | 108 | 5 | 6c106b91e46eabbe686a52a65a9c94ad9cbe9390 | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|LV / Chamber and Cluster_Paper | 1.05e-04 | 192 | 108 | 5 | ad19e2c1d36a0566c9b12ced10db78f4781c8ea6 | |
| ToppCell | droplet-Pancreas-Endocrine|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-04 | 192 | 108 | 5 | 0dfd1e9896c34aee0f842f8de5d0e3af62a15f68 | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial-basal_cell_of_epidermis|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-04 | 192 | 108 | 5 | ec1fd2fb6e71f87189d66261909a84e2be63cacb | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Neuronal-CFuPNs|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.05e-04 | 192 | 108 | 5 | a8841ebd879f1c344ab4246fdef77044170f644d | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Capillary_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-04 | 192 | 108 | 5 | 4bab9754cfd8b9c2d7cc1490e8a29f58c3c26f6c | |
| ToppCell | IPF-Epithelial-Basal|World / Disease state, Lineage and Cell class | 1.05e-04 | 192 | 108 | 5 | 9b91e0b162e6f3ce86dd15cc33c2e745d069581f | |
| ToppCell | COPD-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 1.05e-04 | 192 | 108 | 5 | 62904f94dfce430456f05066522cbf9bd29f4d7e | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.07e-04 | 193 | 108 | 5 | 9f69edc97b868d23998abc98928a2e89a885ef8a | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-04 | 193 | 108 | 5 | be28070c049e7cb68bcd54f582226eb2f5e4bc1c | |
| ToppCell | droplet-Fat-Mat-18m-Endothelial|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-04 | 193 | 108 | 5 | 54024a373e42e1c0bcc327dc084564b83b63a9d4 | |
| ToppCell | droplet-Fat-Mat-18m-Endothelial-endothelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-04 | 193 | 108 | 5 | 81d908594d2983ba7e7c1ec25afdde4315d9690e | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 1.07e-04 | 193 | 108 | 5 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 | |
| Drug | Ant-dATP | 1.69e-09 | 12 | 108 | 5 | CID000131323 | |
| Drug | 2-nitro-5-thiocyanobenzoic acid | 1.03e-07 | 48 | 108 | 6 | CID000092266 | |
| Drug | NSC366363 | 1.04e-07 | 3 | 108 | 3 | CID000339501 | |
| Drug | AC1NDS53 | 1.04e-07 | 3 | 108 | 3 | CID004630710 | |
| Drug | tatsiensine | 1.04e-07 | 3 | 108 | 3 | CID000163526 | |
| Drug | delcosine | 1.04e-07 | 3 | 108 | 3 | CID000120726 | |
| Drug | PDE II | 3.01e-07 | 93 | 108 | 7 | CID003047060 | |
| Drug | Nsc642900 | 4.14e-07 | 4 | 108 | 3 | CID000498959 | |
| Drug | CTK0F9956 | 4.14e-07 | 4 | 108 | 3 | CID011779542 | |
| Drug | 85318-25-8 | 4.14e-07 | 4 | 108 | 3 | CID006439702 | |
| Drug | cloxacepride | 4.14e-07 | 4 | 108 | 3 | CID000068859 | |
| Drug | chloraniformethan | 4.14e-07 | 4 | 108 | 3 | CID000030331 | |
| Drug | Ti 233 | 4.14e-07 | 4 | 108 | 3 | CID000173248 | |
| Drug | diisopropylphosphoramidite | 4.14e-07 | 4 | 108 | 3 | CID000080867 | |
| Drug | herbarumin III | 4.14e-07 | 4 | 108 | 3 | CID000643678 | |
| Drug | thiomethylpromazine | 4.14e-07 | 4 | 108 | 3 | CID000070583 | |
| Drug | KS-504e | 4.14e-07 | 4 | 108 | 3 | CID000129559 | |
| Drug | KS-504d | 4.14e-07 | 4 | 108 | 3 | CID000129557 | |
| Drug | Archanagelicine | 4.14e-07 | 4 | 108 | 3 | CID003083773 | |
| Drug | N,N-dimethyladriamycin-14-valerate | 4.14e-07 | 4 | 108 | 3 | CID000127194 | |
| Drug | Roylin | 4.14e-07 | 4 | 108 | 3 | CID000099924 | |
| Drug | KS-502 | 4.14e-07 | 4 | 108 | 3 | CID000129242 | |
| Drug | KS-501 | 4.14e-07 | 4 | 108 | 3 | CID000129240 | |
| Drug | 2'-methoxykobusin | 4.14e-07 | 4 | 108 | 3 | CID000637889 | |
| Drug | PS-990 | 4.14e-07 | 4 | 108 | 3 | CID000157810 | |
| Drug | NSC 523214 | 5.09e-07 | 147 | 108 | 8 | CID000004752 | |
| Drug | NdCl3 | 6.28e-07 | 15 | 108 | 4 | CID000066204 | |
| Drug | Cocaine | SEMA3F SATB2 CALM1 CALM2 SYNE1 SPTBN1 SPTBN2 OBSCN OBSL1 ADGRL1 GRM1 TRIM3 AP2B1 SLC20A2 MEPCE SNX27 DDX41 HSPA1A HSPA1B PCDH7 SEMA3E | 8.16e-07 | 1314 | 108 | 21 | ctd:D003042 |
| Drug | jujubogenin | 1.03e-06 | 5 | 108 | 3 | CID005318721 | |
| Drug | D 890 | 1.03e-06 | 5 | 108 | 3 | CID000134083 | |
| Drug | NSC-36360 | 1.03e-06 | 5 | 108 | 3 | CID000133340 | |
| Drug | alpha-CAO | 1.03e-06 | 5 | 108 | 3 | CID000196600 | |
| Drug | AC1NS8P3 | 1.03e-06 | 5 | 108 | 3 | CID005356151 | |
| Drug | 4H-1,4-benzothiazin-3-one | 1.03e-06 | 5 | 108 | 3 | CID000021396 | |
| Drug | Y-acid | 1.03e-06 | 5 | 108 | 3 | CID000007022 | |
| Drug | C16AA | 1.03e-06 | 5 | 108 | 3 | CID000488017 | |
| Drug | auranthine | 1.03e-06 | 5 | 108 | 3 | CID000130919 | |
| Drug | Ant-ATP | 1.03e-06 | 5 | 108 | 3 | CID000134953 | |
| Drug | Nor2 chlorpromazine | 1.03e-06 | 5 | 108 | 3 | CID000074981 | |
| Drug | Fsh-beta-(1-15) | 1.03e-06 | 5 | 108 | 3 | CID005748474 | |
| Drug | Ac-dvda | 1.03e-06 | 5 | 108 | 3 | CID000146768 | |
| Drug | VUF 4576 | 1.03e-06 | 5 | 108 | 3 | CID000132784 | |
| Drug | Mastoparan X | 1.09e-06 | 17 | 108 | 4 | CID005488554 | |
| Drug | desmethoxyverapamil | 1.09e-06 | 17 | 108 | 4 | CID000065832 | |
| Drug | 1-isocyanopropane | 1.11e-06 | 39 | 108 | 5 | CID000079084 | |
| Drug | chlorpromazine sulfoxide | 1.39e-06 | 18 | 108 | 4 | CID000070413 | |
| Drug | 8-azido cyclic AMP | 1.39e-06 | 18 | 108 | 4 | CID000115296 | |
| Drug | dysprosium | 1.41e-06 | 74 | 108 | 6 | CID000023912 | |
| Drug | phenylpiperazine | 1.43e-06 | 41 | 108 | 5 | CID000007096 | |
| Drug | MABI | 1.76e-06 | 19 | 108 | 4 | CID000188268 | |
| Drug | AC1NSV6X | 2.05e-06 | 6 | 108 | 3 | CID005317173 | |
| Drug | N-(8-aminooctyl)-5-iodonaphthalene-1-sulfonamide | 2.05e-06 | 6 | 108 | 3 | CID000004307 | |
| Drug | 2,5-diketocamphane | 2.05e-06 | 6 | 108 | 3 | CID000020218 | |
| Drug | benziodarone | 2.05e-06 | 6 | 108 | 3 | CID000006237 | |
| Drug | AC1LCMSV | 2.05e-06 | 6 | 108 | 3 | CID000633347 | |
| Drug | CI-922 | 2.05e-06 | 6 | 108 | 3 | CID000146938 | |
| Drug | caged PE | 2.05e-06 | 6 | 108 | 3 | CID000192405 | |
| Drug | propyl-methylenedioxyindene | 2.05e-06 | 6 | 108 | 3 | CID000145934 | |
| Drug | plakin | 2.59e-06 | 82 | 108 | 6 | CID000018752 | |
| Drug | AC1Q6SL6 | 2.86e-06 | 47 | 108 | 5 | CID000000198 | |
| Drug | 1-(4-pyridyl)ethanol | 3.58e-06 | 7 | 108 | 3 | CID000090919 | |
| Drug | AC1L52O2 | 3.58e-06 | 7 | 108 | 3 | CID000196983 | |
| Drug | chloronitromethane | 3.58e-06 | 7 | 108 | 3 | CID000074529 | |
| Drug | trifluoperazine sulfoxide | 3.58e-06 | 7 | 108 | 3 | CID000159622 | |
| Drug | DyCl3 | 3.58e-06 | 7 | 108 | 3 | CID000066207 | |
| Drug | DAPpNP | 3.58e-06 | 7 | 108 | 3 | CID005492375 | |
| Drug | T 7188 | 3.58e-06 | 7 | 108 | 3 | CID000003311 | |
| Drug | MS-857 | 3.58e-06 | 7 | 108 | 3 | CID000129517 | |
| Drug | SQ 65442 | 3.58e-06 | 7 | 108 | 3 | CID000128039 | |
| Drug | AC1L3PE4 | 3.58e-06 | 7 | 108 | 3 | CID000093048 | |
| Drug | O-4-(ethoxybutyl)berbamine | 3.58e-06 | 7 | 108 | 3 | CID000188375 | |
| Drug | TZC-5665 | 3.58e-06 | 7 | 108 | 3 | CID006449836 | |
| Drug | KHL-8430 | 3.58e-06 | 7 | 108 | 3 | CID000195711 | |
| Drug | CPU57 | 3.58e-06 | 7 | 108 | 3 | CID000195730 | |
| Drug | Drnflrfamide | 3.58e-06 | 7 | 108 | 3 | CID000132879 | |
| Drug | 4-hydroxyphenylglycol | 3.58e-06 | 7 | 108 | 3 | CID003081980 | |
| Drug | asocainol | 3.58e-06 | 7 | 108 | 3 | CID000071161 | |
| Drug | PDE I | 4.73e-06 | 24 | 108 | 4 | CID000198428 | |
| Drug | HF-2035 | 5.61e-06 | 25 | 108 | 4 | CID006439511 | |
| Drug | proxyl nitroxide | 5.71e-06 | 8 | 108 | 3 | CID000076702 | |
| Drug | niludipine | 5.71e-06 | 8 | 108 | 3 | CID000089767 | |
| Drug | Ro 22-4839 | 5.71e-06 | 8 | 108 | 3 | CID000065839 | |
| Drug | HT-74 | 5.71e-06 | 8 | 108 | 3 | CID000126681 | |
| Drug | 2,6-ANS | 5.71e-06 | 8 | 108 | 3 | CID002762570 | |
| Drug | AC1MJ4D0 | 5.71e-06 | 8 | 108 | 3 | CID003085362 | |
| Drug | 3,7,8-trihydroxy-CPZ | 5.71e-06 | 8 | 108 | 3 | CID000467415 | |
| Drug | KS-504a | 5.71e-06 | 8 | 108 | 3 | CID000129577 | |
| Drug | NSP-805 | 5.71e-06 | 8 | 108 | 3 | CID000130349 | |
| Drug | dithiotreitol | HK1 CALM1 CALM2 CALM3 SPTBN1 SPTBN2 LAMA5 SIRT1 TRIM3 SPTBN4 TXNL1 | 6.40e-06 | 430 | 108 | 11 | CID000019001 |
| Drug | AC1OCACU | 7.72e-06 | 27 | 108 | 4 | CID006914631 | |
| Drug | w66 | 8.54e-06 | 9 | 108 | 3 | CID006439460 | |
| Drug | 7,8-diOH-CPZ | 8.54e-06 | 9 | 108 | 3 | CID000159916 | |
| Drug | adamantanone | 8.54e-06 | 9 | 108 | 3 | CID000064151 | |
| Drug | picumast | 8.54e-06 | 9 | 108 | 3 | CID000431850 | |
| Drug | 5-exo-hydroxycamphor | 8.54e-06 | 9 | 108 | 3 | CID000440017 | |
| Drug | KS-505a | 8.54e-06 | 9 | 108 | 3 | CID003081782 | |
| Drug | Kr I | 1.22e-05 | 10 | 108 | 3 | CID005288675 | |
| Drug | 1-isoamyl-3-isobutylxanthine | 1.22e-05 | 10 | 108 | 3 | CID000152034 | |
| Drug | norchlorpromazine | 1.22e-05 | 10 | 108 | 3 | CID000062875 | |
| Drug | AC1L8MM4 | 1.22e-05 | 10 | 108 | 3 | CID000429016 | |
| Disease | Global developmental delay | 2.87e-08 | 133 | 106 | 8 | C0557874 | |
| Disease | spinocerebellar ataxia type 5 (implicated_via_orthology) | 1.80e-07 | 4 | 106 | 3 | DOID:0050882 (implicated_via_orthology) | |
| Disease | graft-versus-host disease (biomarker_via_orthology) | 4.48e-07 | 5 | 106 | 3 | DOID:0081267 (biomarker_via_orthology) | |
| Disease | VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1 (disorder) | 5.31e-06 | 10 | 106 | 3 | C1631597 | |
| Disease | lobe attachment | 1.02e-05 | 207 | 106 | 7 | EFO_0007667 | |
| Disease | multisite chronic pain | 2.44e-05 | 95 | 106 | 5 | EFO_0010100 | |
| Disease | 3-M syndrome | 3.83e-05 | 3 | 106 | 2 | cv:C1848862 | |
| Disease | 3-M syndrome (is_implicated_in) | 3.83e-05 | 3 | 106 | 2 | DOID:0060241 (is_implicated_in) | |
| Disease | response to antipsychotic drug | 6.57e-05 | 60 | 106 | 4 | GO_0097332 | |
| Disease | retinitis pigmentosa | 1.90e-04 | 6 | 106 | 2 | MONDO_0019200 | |
| Disease | Intellectual Disability | 2.15e-04 | 447 | 106 | 8 | C3714756 | |
| Disease | Phencyclidine-Related Disorders | 2.65e-04 | 7 | 106 | 2 | C0236742 | |
| Disease | anxiety, vitamin D measurement | 2.65e-04 | 7 | 106 | 2 | EFO_0004631, EFO_0005230 | |
| Disease | Phencyclidine Abuse | 2.65e-04 | 7 | 106 | 2 | C0031391 | |
| Disease | Major depression, single episode | 4.53e-04 | 9 | 106 | 2 | C0024517 | |
| Disease | progression free survival, response to carboplatin, methylcobalamin deficiency type cblE, ovarian serous carcinoma | 4.67e-04 | 42 | 106 | 3 | EFO_0004920, EFO_1001516, GO_0097328, MONDO_0009354 | |
| Disease | Cannabis Abuse | 5.65e-04 | 10 | 106 | 2 | C0006868 | |
| Disease | Cannabis-Related Disorder | 5.65e-04 | 10 | 106 | 2 | C0236735 | |
| Disease | Hashish Abuse | 5.65e-04 | 10 | 106 | 2 | C0018614 | |
| Disease | lower face morphology measurement | 6.55e-04 | 109 | 106 | 4 | EFO_0010948 | |
| Disease | response to tenofovir, creatinine clearance measurement | 7.25e-04 | 112 | 106 | 4 | EFO_0007934, EFO_0009279 | |
| Disease | Cooley's anemia | 8.24e-04 | 12 | 106 | 2 | C0002875 | |
| Disease | Thalassemia Intermedia | 8.24e-04 | 12 | 106 | 2 | C0271979 | |
| Disease | Thalassemia Minor | 8.24e-04 | 12 | 106 | 2 | C0085578 | |
| Disease | beta Thalassemia | 8.24e-04 | 12 | 106 | 2 | C0005283 | |
| Disease | Huntington's disease (is_marker_for) | 9.26e-04 | 53 | 106 | 3 | DOID:12858 (is_marker_for) | |
| Disease | obesity (implicated_via_orthology) | 1.09e-03 | 215 | 106 | 5 | DOID:9970 (implicated_via_orthology) | |
| Disease | Sarcomatoid Renal Cell Carcinoma | 1.19e-03 | 128 | 106 | 4 | C1266043 | |
| Disease | Chromophobe Renal Cell Carcinoma | 1.19e-03 | 128 | 106 | 4 | C1266042 | |
| Disease | Collecting Duct Carcinoma of the Kidney | 1.19e-03 | 128 | 106 | 4 | C1266044 | |
| Disease | Papillary Renal Cell Carcinoma | 1.19e-03 | 128 | 106 | 4 | C1306837 | |
| Disease | Renal Cell Carcinoma | 1.19e-03 | 128 | 106 | 4 | C0007134 | |
| Disease | Hemoglobin F Disease | 1.30e-03 | 15 | 106 | 2 | C0019025 | |
| Disease | Romano-Ward Syndrome | 1.48e-03 | 16 | 106 | 2 | C0035828 | |
| Disease | platelet component distribution width | 1.62e-03 | 755 | 106 | 9 | EFO_0007984 | |
| Disease | Cannabis Dependence | 1.68e-03 | 17 | 106 | 2 | C0006870 | |
| Disease | Sclerocystic Ovaries | 1.84e-03 | 144 | 106 | 4 | C1136382 | |
| Disease | Polycystic Ovary Syndrome | 1.84e-03 | 144 | 106 | 4 | C0032460 | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 2.03e-03 | 148 | 106 | 4 | C0279702 | |
| Disease | temporal horn of lateral ventricle volume measurement | 2.24e-03 | 72 | 106 | 3 | EFO_0010333 | |
| Disease | unipolar depression, bipolar disorder, schizophrenia | 2.33e-03 | 20 | 106 | 2 | EFO_0003761, MONDO_0004985, MONDO_0005090 | |
| Disease | migraine disorder, endometriosis | 2.33e-03 | 73 | 106 | 3 | EFO_0001065, MONDO_0005277 | |
| Disease | muscular dystrophy (implicated_via_orthology) | 2.57e-03 | 21 | 106 | 2 | DOID:9884 (implicated_via_orthology) | |
| Disease | apolipoprotein B measurement | 2.73e-03 | 663 | 106 | 8 | EFO_0004615 | |
| Disease | post-traumatic stress disorder symptom measurement | 3.25e-03 | 82 | 106 | 3 | EFO_0008535 | |
| Disease | cystatin C measurement | 3.35e-03 | 402 | 106 | 6 | EFO_0004617 | |
| Disease | peptic ulcer disease, Peptic ulcer and gastro-oesophageal reflux disease (GORD) drug use measurement, gastroesophageal reflux disease | 3.35e-03 | 24 | 106 | 2 | EFO_0003948, EFO_0009923, MONDO_0004247 | |
| Disease | Carcinoma, Pancreatic Ductal | 3.35e-03 | 24 | 106 | 2 | C0887833 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SGEILDVFDAAERYQ | 746 | P21399 | |
| DELAASAYQAVEVDR | 451 | O75366 | |
| IVGEYAERIDNADEL | 451 | P63010 | |
| VTENEEFNIGDIVRY | 2306 | Q7Z408 | |
| IREADIDGDGQVNYE | 126 | P0DP25 | |
| LVDSVDDAEGLYVAV | 26 | Q6ZNE5 | |
| VYVDDDSEAAGNRVD | 331 | O94910 | |
| EEVVERANNTRYGLA | 431 | P30837 | |
| EGYEVLRFDDVVTNV | 121 | Q86Z23 | |
| LRFDDVVTNVGNAYE | 126 | Q86Z23 | |
| EVLYLRNVSAEDAGE | 316 | P22455 | |
| YGRVTAGNDEVEAAA | 686 | Q9NP58 | |
| IVGEYAERIDNADEL | 451 | Q10567 | |
| EDTGENARITYVIQD | 816 | Q9NYQ6 | |
| ADVDQDGRVNYEEFA | 126 | Q9NZT1 | |
| IREADIDGDGQVNYE | 126 | P0DP24 | |
| RQVVRGYAEQDSEVD | 221 | Q9P241 | |
| AADDDYNIEVLLGVD | 261 | O95450 | |
| REALLGVQEDVDEYV | 41 | Q14257 | |
| REAAEAEAEVPVVQY | 36 | Q96I51 | |
| AEAEVPVVQYVGERA | 41 | Q96I51 | |
| QQEGVVREVNDAIYD | 416 | Q9ULW6 | |
| AAEEYDILVAEETAG | 506 | Q9Y5P8 | |
| AEYEAIVREVEGDLG | 31 | Q4KMZ1 | |
| GIEAAYEIEARNQVF | 331 | P39900 | |
| IYGVEVEVRDINDNA | 116 | O60330 | |
| GSIIAEVRAQYEEIA | 351 | Q01546 | |
| VQSAGDAIRAIYAED | 146 | Q7L1V2 | |
| ARLVAGLEDVQVYDG | 616 | O75147 | |
| DGIIAEVKAQYEEVA | 331 | Q9NSB2 | |
| GLNNVIAIDFDYREE | 3041 | Q9NZR2 | |
| IAEGSEDQVLYIAND | 3881 | Q9NZR2 | |
| TADDLIDVVEGNRVY | 226 | Q9Y295 | |
| VSRGAQEDIEEYSAD | 1461 | Q5T1H1 | |
| AAEGRAVYVVDDAAV | 26 | Q96EK9 | |
| AVYVVDDAAVLGAED | 31 | Q96EK9 | |
| VTGNYVLDRDDLVEA | 556 | Q7L2J0 | |
| SVADERVDYVVVDQQ | 651 | Q13480 | |
| GIQLEEAGEYRCEVV | 111 | Q68D85 | |
| DEAVAYGAAVQAAIL | 366 | P0DMV9 | |
| GIEALEAAIEYRNES | 1061 | Q86VH2 | |
| INGRAYADEVAVAEE | 1141 | Q9Y4D7 | |
| RAADLDVGVNGQIEY | 331 | O60245 | |
| EEQVVTADFINRGEY | 826 | Q8NCN5 | |
| TADFINRGEYEIDIA | 831 | Q8NCN5 | |
| VEADEYQGAVASRVL | 441 | Q14999 | |
| EIEVLAANIDYINDG | 981 | O75037 | |
| DDVIYHEAAVRQAGA | 1166 | Q92616 | |
| LVVEYANEDARQEVG | 1111 | O15230 | |
| AGAASLDVIQEVEYV | 401 | Q9UJV9 | |
| RGDYDANIVAVVNDT | 196 | P19367 | |
| SEDYVDIVQGNRVGV | 441 | O00469 | |
| VNEAGEDSLQYDVRV | 2851 | Q96RW7 | |
| YRAAVREDAQPGAEV | 301 | Q6V1P9 | |
| DARGEIFDIYVVTAD | 5596 | Q5VST9 | |
| AEQDAITLREGQYVE | 5616 | Q5VST9 | |
| EEAAGYAQESQREEA | 486 | Q8NCB2 | |
| ENEFIDASRLVYDGV | 606 | P26232 | |
| DVVIETDFGLRVAYD | 2556 | Q9Y6R7 | |
| VDDYVASEGAVQRVL | 201 | Q9H972 | |
| DREQRAVYDEQGTVD | 71 | Q8WXX5 | |
| DVLVEYQGEGRNVTD | 411 | P15586 | |
| IREADIDGDGQVNYE | 126 | P0DP23 | |
| EARVAQGIREEEVSY | 786 | Q9NV70 | |
| DEAVAYGAAVQAAIL | 366 | P0DMV8 | |
| DNTDIYVGDRAIDNI | 1076 | P82279 | |
| ADRDEVIEGYEVEAN | 321 | Q13255 | |
| VLAEAQVGDERDYVC | 111 | P50895 | |
| GCRVEDYDAADDVQL | 336 | P50895 | |
| YCNAVAEAEIEAEEG | 436 | Q08357 | |
| VNYEGADRVEFVIET | 41 | Q7Z5L9 | |
| FSGDAVQVQEYREAL | 341 | P46019 | |
| YVEVRDGDNRDGQII | 181 | Q6UXH9 | |
| DEAVAYGAAVQAAIL | 366 | P11142 | |
| RAVGVQNYLEEAAER | 36 | Q8N0Z8 | |
| AEAVDIDRSVAQYTG | 281 | Q10713 | |
| SFLGRYQAVQEAVED | 881 | P46939 | |
| EGREFDYVINDLTAV | 266 | P52788 | |
| IAVDQVDAADGRYEV | 466 | Q13275 | |
| GVNFEAVLRVEEEEA | 211 | Q6UWJ1 | |
| YRDEVEEVGARAQEI | 3651 | Q8NF91 | |
| EQVAREHEEYQAGVD | 216 | Q6ZMZ3 | |
| DLEGNSVEDLGQVRY | 166 | Q8IYG6 | |
| YEEFVGLNEVREAQG | 86 | Q96ER9 | |
| RDVAEYSEAKEVRGV | 526 | Q9BXS9 | |
| NDRVVAVGYINEAID | 451 | Q13576 | |
| ANAVAEGIRSEENIY | 251 | Q8TDQ0 | |
| YNLGVREDEVVVNDV | 2451 | Q8NFP9 | |
| TSVDAAEDYAEGVRV | 186 | Q02127 | |
| VDGANINITAAIYDE | 476 | Q9UPW6 | |
| EEEEAAAAAIGYRDN | 131 | Q96EB6 | |
| RAVVQYLVEEGAAID | 1191 | Q9C0D5 | |
| DEYANVDAIVVSVGV | 26 | Q9Y5B9 | |
| AIETDIAAYEERVQA | 466 | Q01082 | |
| IAAYEERVQAVVAVA | 471 | Q01082 | |
| EREEYVQEDAGIIFV | 151 | Q08188 | |
| YIIREGQLAVVADDG | 386 | Q8IV77 | |
| RNDSLAGVVIADNEY | 71 | O15498 | |
| GDQILAVDDEIVVGY | 1526 | O75970 | |
| ETDIVAYSGRVQAVD | 471 | O15020 | |
| AYSGRVQAVDAVAAE | 476 | O15020 | |
| EVEGDNRYIANTVEL | 351 | P04844 | |
| DAGDYRDTQDALAVV | 1036 | Q6ZV73 | |
| QDFNVGDYIEAVLDR | 256 | P11216 | |
| YDFIEDQGGLEAVRQ | 291 | P42768 | |
| INVQIDDSYLVEAGD | 276 | Q8N1W2 | |
| DENYNGVSDVELRVA | 266 | Q96L92 | |
| ADIAAYEERVQGVAE | 476 | Q9H254 | |
| IAVDRVEAEDGQYDV | 436 | O15041 | |
| VDRVEAEDGTYDVIF | 441 | Q9NS98 | |
| AVVYVSLDNAVLGDD | 501 | Q9UP52 | |
| EARGVVENYNDEEVS | 631 | O94782 | |
| VENYNDEEVSIRVGG | 636 | O94782 | |
| VDTNGDIIVADYDNR | 541 | O75382 | |
| VRIDQYQGADAVGLE | 86 | O43396 | |
| VLEQVEAYQAEAREA | 876 | P41229 | |
| EIAIYQDDLEGDAQV | 496 | P54296 | |
| DEVSFRDGDYIVNVQ | 971 | O76041 |